##	TAG	<div1>
##	TAG	<head>
1	TOK	MAGIC	BOS	magic\JA
2	TOK	BULLETS		bullet\N5P
3	TOK	FLY		fly\N5S
4	TOK	AGAIN	EOS	AGAIN\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
6	TOK	Molecular	BOS	molecular\JA
7	TOK	guided		guide\VMC----
8	TOK	missiles		missile\N5P
9	TOK	called		call\VMF6A66
10	TOK	monoclonal		monoclonal\JA
11	TOK	antibodies		antibody\N5P
12	TOK	were		be\V6F-A66
13	TOK	poised		poise\VMC----
14	TOK	to		to\P
15	TOK	shoot		shoot\N5S
16	TOK	down		down\DGA7
17	TOK	cancer		cancer\N5S
18	TOK	and		and\CC
19	TOK	a		a\AI---S
20	TOK	host		host\N5S
21	TOK	of		of\P
22	TOK	other		other\JA
23	TOK	diseases		disease\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
24	TOK	until		until\CS
25	TOK	they		they\RPP3NN
26	TOK	crashed		crash\VMF6A66
27	TOK	and		and\CC
28	TOK	burned		burn\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
29	TOK	Now	BOS	now\DGA7
30	TOK	a		a\AI---S
31	TOK	new		new\JA
32	TOK	generation		generation\N5S
33	TOK	is		be\V6FDRS3
34	TOK	soaring		soar\VMG----
35	TOK	to		to\P
36	TOK	market		market\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
37	TOK	The	BOS	the\AT---6
38	TOK	unbridled		unbridle\VMC----
39	TOK	optimism		optimism\N5S
40	TOK	that		that\RW63N6
41	TOK	surrounded		surround\VMF6A66
42	TOK	monoclonal		monoclonal\JA
43	TOK	antibodies		antibody\N5P
44	TOK	in		in\P
45	TOK	the		the\AT---6
##	TAG	<na type="code">
46	TOK	1980s		noanat\W
##	TAG	</na>
47	TOK	was		be\V6F-A66
48	TOK	infectious		infectious\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
49	TOK	You	BOS	you\RP62N6
50	TOK	had		have\V6F6A66
51	TOK	to		to\P
52	TOK	be		be\VMI----
53	TOK	the		the\AT---6
54	TOK	world		world\N5S
55	PGR	's		genmark\GENMARK
56	TOK	toughest		tough\JS
57	TOK	cynic		cynic\N5S
58	TOK	not		not\DGA7
59	TOK	to		to\P
60	TOK	be		be\VMI----
61	TOK	dazzled		dazzle\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
62	TOK	Got	BOS	get\VMC----
63	TOK	cancer		cancer\N5S
---	DLD	?	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
64	TOK	No	BOS	no\N5S
65	TOK	problem		problem\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
66	TOK	Like	BOS	like\P
67	TOK	heat		heat\N5S
---	DLI	-		=\DELIM
68	TOK	seeking		seek\VMG----
69	TOK	missiles		missile\N5P
---	DLD	,		=\DELIM
70	TOK	monoclonal		monoclonal\JA
71	TOK	antibodies		antibody\N5P
72	TOK	tipped		tip\VMF6A66
73	TOK	with		with\P
74	TOK	poisons		poison\N5P
75	TOK	or		or\CC
76	TOK	radioactive		radioactive\JA
77	TOK	isotopes		isotope\N5P
78	TOK	would		will\VOFDA66
79	TOK	home		home\N5S
80	TOK	in		in\P
81	TOK	on		on\P
82	TOK	malignant		malignant\JA
83	TOK	cells		cell\N5P
84	TOK	and		and\CC
85	TOK	deliver		deliver\VMI----
86	TOK	their		their\APP3N6
87	TOK	deadly		deadly\JA
88	TOK	payloads		payload\N5P
---	DLD	,		=\DELIM
89	TOK	wiping		wipe\VMG----
90	TOK	out		out\DGA7
91	TOK	cancer		cancer\N5S
92	TOK	while		while\CS
93	TOK	leaving		leave\VMG----
94	TOK	normal		normal\JA
95	TOK	cells		cell\N5P
96	TOK	intact		intact\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
97	TOK	How	BOS	how\DGAW
98	TOK	about		about\DGA7
99	TOK	an		an\AI---S
100	TOK	infectious		infectious\JA
101	TOK	disease		disease\N5S
---	DLD	?	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
102	TOK	All	BOS	all\N56
103	TOK	would		will\VOFDA66
104	TOK	be		be\VMI----
105	TOK	well		well\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
106	TOK	Monoclonals	BOS	monoclonal\N5P
107	TOK	would		will\VOFDA66
108	TOK	surround		surround\VMI----
109	TOK	marauding		maraud\VMG----
110	TOK	viruses		virus\N5P
111	TOK	and		and\CC
112	TOK	bacteria		bacteria\N5P
113	TOK	like		like\P
114	TOK	goombahs		goombah\N5P
115	TOK	from		from\P
##	TAG	<name>
116	TOK	Tony Soprano		Tony_Soprano\N46
##	TAG	</name>
117	PGR	's		genmark\GENMARK
118	TOK	crew		crow\VMF6A66
---	DLD	,		=\DELIM
119	TOK	muscling		muscle\VMG----
120	TOK	them		them\RPP3NA
121	TOK	into		into\P
122	TOK	secluded		seclude\VMC----
123	TOK	byways		byway\N5P
124	TOK	where		where\CS
125	TOK	killer		killer\N5S
126	TOK	cells		cell\N5P
127	TOK	of		of\P
128	TOK	the		the\AT---6
129	TOK	immune		immune\JA
130	TOK	system		system\N5S
131	TOK	would		will\VOFDA66
132	TOK	make		make\VMI----
133	TOK	them		them\RPP3NA
134	TOK	an		an\AI---S
135	TOK	offer		offer\N5S
136	TOK	they		they\RPP3NN
137	TOK	couldn		could\VOFDA66
138	PGR	't		not\DGA7
139	TOK	refuse		refuse\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
140	TOK	If	BOS	if\CS
141	TOK	only		only\JA
142	TOK	things		thing\N5P
143	TOK	had		have\V6F6A66
144	TOK	been		be\VMC----
145	TOK	so		so\DGA7
146	TOK	simple		simple\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
147	TOK	Monoclonal	BOS	monoclonal\JA
148	TOK	antibodies		antibody\N5P
149	TOK	are		be\V6FDR66
150	TOK	highly		highly\DGA7
151	TOK	pure		pure\JA
152	TOK	populations		population\N5P
153	TOK	of		of\P
154	TOK	immune		immune\JA
155	TOK	system		system\N5S
156	TOK	proteins		protein\N5P
157	TOK	that		that\RW63N6
158	TOK	attack		attack\VMF6R66
159	TOK	specific		specific\JA
160	TOK	molecular		molecular\JA
161	TOK	targets		target\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
162	TOK	Unfortunately	BOS	unfortunately\DGA7
---	DLD	,		=\DELIM
163	TOK	people		people\N56
164	TOK	who		who\RW63N-
165	TOK	received		receive\VMF6A66
166	TOK	infusions		infusion\N5P
167	TOK	of		of\P
168	TOK	the		the\AT---6
169	TOK	early		early\JA
170	TOK	therapeutic		therapeutic\JA
171	TOK	monoclonal		monoclonal\JA
172	TOK	antibodies		antibody\N5P
173	TOK	tended		tend\VMF6A66
174	TOK	to		to\P
175	TOK	develop		develop\VMI----
176	TOK	their		their\APP3N6
177	TOK	own		own\JA
178	TOK	antibodies		antibody\N5P
179	TOK	against		against\P
180	TOK	the		the\AT---6
181	TOK	foreign		foreign\JA
182	TOK	ones		one\RIP3N-
---	DLD	,		=\DELIM
183	TOK	which		which\RW63N-
184	TOK	caused		cause\VMF6A66
185	TOK	them		them\RPP3NA
186	TOK	to		to\P
187	TOK	become		become\VMI----
188	TOK	even		even\DGA7
189	TOK	sicker		sicker\JA
190	TOK	for		for\P
191	TOK	reasons		reason\N5P
192	TOK	that		that\RW63N6
193	TOK	are		be\V6FDR66
194	TOK	not		not\DGA7
195	TOK	entirely		entirely\DGA7
196	TOK	clear		clear\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
197	TOK	And	BOS	and\CC
198	TOK	the		the\AT---6
199	TOK	liver		liver\N5S
200	TOK	showed		show\VMF6A66
201	TOK	a		a\AI---S
202	TOK	predilection		predilection\N5S
203	TOK	for		for\P
204	TOK	these		this\AD---P
205	TOK	early		early\JA
206	TOK	monoclonals		monoclonal\N5P
---	DLD	,		=\DELIM
207	TOK	sopping		sop\VMG----
208	TOK	them		them\RPP3NA
209	TOK	up		up\P
210	TOK	before		before\CS
211	TOK	they		they\RPP3NN
212	TOK	could		can\VOFDA66
213	TOK	target		target\VMI----
214	TOK	their		their\APP3N6
215	TOK	quarries		quarry\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
216	TOK	Clinical	BOS	clinical\JA
217	TOK	trials		trial\N5P
218	TOK	failed		fail\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
219	TOK	Stocks	BOS	stock\N5P
220	TOK	plunged		plunge\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
221	TOK	Millions	BOS	million\N5P
222	TOK	of		of\P
223	TOK	dollars		dollar\N5P
224	TOK	were		be\V6F-A66
225	TOK	lost		lose\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
226	TOK	And	BOS	and\CC
227	TOK	a		a\AI---S
228	TOK	generation		generation\N5S
229	TOK	of		of\P
230	TOK	scientists		scientist\N5P
231	TOK	and		and\CC
232	TOK	biotechnology		biotechnology\N5S
233	TOK	businesspeople		businesspeople\N5P
234	TOK	developed		develop\VMF6A66
235	TOK	the		the\AT---6
236	TOK	skepticism		skepticism\N5S
237	TOK	shared		share\VMC----
238	TOK	only		only\DGA7
239	TOK	by		by\P
240	TOK	the		the\AT---6
241	TOK	once		once\DGA7
242	TOK	burned		burn\VMF6A66
---	DLD	,		=\DELIM
243	TOK	twice		twice\DGA7
244	TOK	shy		shy\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
245	TOK	Luckily	BOS	luckily\DGA7
---	DLD	,		=\DELIM
246	TOK	some		some\AG---6
247	TOK	of		of\P
248	TOK	those		that\AD---P
249	TOK	individuals		individual\N5P
250	TOK	soldiered		soldier\VMC----
251	TOK	on		on\P
252	TOK	despite		despite\P
253	TOK	the		the\AT---6
254	TOK	bad		bad\JA
255	TOK	news		news\N56
256	TOK	and		and\CC
257	TOK	found		find\VMF6A66
258	TOK	ways		way\N5P
259	TOK	to		to\P
260	TOK	overcome		overcome\VMI----
261	TOK	the		the\AT---6
262	TOK	failings		failing\N5P
263	TOK	of		of\P
264	TOK	the		the\AT---6
265	TOK	early		early\JA
266	TOK	versions		version\N5P
267	TOK	of		of\P
268	TOK	the		the\AT---6
269	TOK	drugs		drug\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
270	TOK	Now	BOS	now\DGA7
271	TOK	many		many\RIP3N-
272	TOK	are		be\V6FDR66
273	TOK	hoping		hope\VMG----
274	TOK	that		that\AD---S
##	TAG	<num>
275	TOK	2001		2001\X
##	TAG	</num>
276	TOK	will		will\VOFDR66
277	TOK	be		be\VMI----
278	TOK	the		the\AT---6
##	TAG	<name>
279	TOK	Year		Year\N46
##	TAG	</name>
280	TOK	of		of\P
281	TOK	the		the\AT---6
##	TAG	<name>
282	TOK	Monoclonals		Monoclonals\N46
##	TAG	</name>
---	DLE	,		=\DELIM
283	TOK	when		when\CS
284	TOK	their		their\APP3N6
285	TOK	perseverance		perseverance\N5S
286	TOK	will		will\VOFDR66
287	TOK	pay		pay\VMI----
288	TOK	off		off\DGA7
289	TOK	in		in\P
290	TOK	the		the\AT---6
291	TOK	form		form\N5S
292	TOK	of		of\P
##	TAG	<loc pos="DGA7">
293	TOK	lots of		lots_of\DGA7
##	TAG	</loc>
294	TOK	effective		effective\JA
295	TOK	monoclonal		monoclonal\JA
296	TOK	antibody		antibody\N5S
---	DLI	-		=\DELIM
297	TOK	based		base\VMC----
298	TOK	drugs		drug\N5P
299	TOK	approved		approve\VMC----
300	TOK	or		or\CC
301	TOK	under		under\P
302	TOK	evaluation		evaluation\N5S
303	TOK	by		by\P
304	TOK	the		the\AT---6
##	TAG	<name>
305	TOK	U.S		U.S\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
306	TOK	Food	BOS	food\N5S
307	TOK	and		and\CC
##	TAG	<name>
308	TOK	Drug Administration		Drug_Administration\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
309	TOK	Antibodies		antibody\N5P
310	TOK	will		will\VOFDR66
311	TOK	be		be\VMI----
312	TOK	surging		surge\VMG----
313	TOK	ahead		ahead\DGA7
---	DLD	,		=\DELIM
---	DLD	"		=\DELIM
314	TOK	says		say\VMFDRS3
##	TAG	<name>
315	TOK	Franklin M. Berger		Franklin_M._Berger\N46
##	TAG	</name>
---	DLE	,		=\DELIM
316	TOK	a		a\AI---S
317	TOK	biotech		biotech\N5S
318	TOK	analyst		analyst\N5S
319	TOK	with		with\P
##	TAG	<name>
320	TOK	JP Morgan Securities		JP_Morgan_Securities\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
321	TOK	He	BOS	he\RPS3MN
322	TOK	predicts		predict\VMFDRS3
323	TOK	that		that\CS
324	TOK	soon		soon\DGA7
325	TOK	there		there\DGA7
326	TOK	will		will\VOFDR66
327	TOK	be		be\VMI----
328	TOK	so		so\DGA7
329	TOK	many		many\AI---P
330	TOK	monoclonal		monoclonal\JA
331	TOK	antibodies		antibody\N5P
332	TOK	awaiting		await\VMG----
333	TOK	approval		approval\N5S
334	TOK	by		by\P
335	TOK	the		the\AT---6
##	TAG	<name>
336	TOK	FDA		FDA\N46
##	TAG	</name>
337	TOK	that		that\CS
338	TOK	they		they\RPP3NN
339	TOK	will		will\VOFDR66
340	TOK	cause		cause\VMI----
341	TOK	a		a\AI---S
342	TOK	bottleneck		bottleneck\N5S
343	TOK	in		in\P
344	TOK	the		the\AT---6
345	TOK	review		review\N5S
346	TOK	process		process\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
347	TOK	Ten	BOS	Ten\X
##	TAG	</num>
348	TOK	monoclonals		monoclonal\N5P
349	TOK	have		have\V6F6R66
350	TOK	reached		reach\VMC----
351	TOK	the		the\AT---6
352	TOK	market		market\N5S
---	DLD	,		=\DELIM
353	TOK	and		and\CC
##	TAG	<num>
354	TOK	three		three\X
##	TAG	</num>
355	TOK	await		await\VMF6R66
##	TAG	<name>
356	TOK	FDA		FDA\N46
##	TAG	</name>
357	TOK	approval		approval\N5S
---	DLD	,		=\DELIM
358	TOK	including		including\P
359	TOK	the		the\AT---6
360	TOK	first		first\MOS
##	TAG	<num>
361	TOK	two		two\X
##	TAG	</num>
362	TOK	that		that\RW63N6
363	TOK	would		will\VOFDA66
364	TOK	be		be\VMI----
365	TOK	equipped		equip\VMC----
366	TOK	to		to\P
367	TOK	deliver		deliver\VMI----
368	TOK	a		a\AI---S
369	TOK	dose		dose\N5S
370	TOK	of		of\P
371	TOK	radiation		radiation\N5S
---	DLE	[		=\DELIM
372	TOK	see		see\VMF6R66
373	TOK	table		table\VMF6R66
---	DLD	]		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
374	TOK	Another	BOS	another\RIS3N-
##	TAG	<num>
375	TOK	100		100\X
##	TAG	</num>
376	TOK	or		or\CC
377	TOK	more		many\JC
378	TOK	antibodies		antibody\N5P
379	TOK	are		be\V6FDR66
380	TOK	being		be\VMG----
381	TOK	tested		test\VMC----
382	TOK	in		in\P
383	TOK	humans		human\N5P
---	DLD	,		=\DELIM
384	TOK	having		have\VMG----
385	TOK	already		already\DGA7
386	TOK	shown		show\VMC----
387	TOK	promise		promise\N5S
388	TOK	in		in\P
389	TOK	tests		test\N5P
390	TOK	involving		involve\VMG----
391	TOK	animals		animal\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
392	TOK	But	BOS	but\CC
393	TOK	this		this\AD---S
394	TOK	summer		summer\N5S
395	TOK	the		the\AT---6
##	TAG	<name>
396	TOK	FDA		FDA\N46
##	TAG	</name>
397	TOK	sent		send\VMF6A66
398	TOK	a		a\AI---S
399	TOK	message		message\N5S
400	TOK	that		that\RW63N6
401	TOK	could		can\VOFDA66
402	TOK	slow		slow\VMI----
403	TOK	the		the\AT---6
404	TOK	monoclonal		monoclonal\JA
405	TOK	juggernaut		juggernaut\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
406	TOK	In	BOS	in\P
##	TAG	<loc pos="N5S">
407	TOK	July		july\N5S
##	TAG	</loc>
408	TOK	the		the\AT---6
409	TOK	agency		agency\N5S
410	TOK	told		tell\VMF6A66
##	TAG	<name>
411	TOK	Genentech		Genentech\N46
##	TAG	</name>
---	DLE	,		=\DELIM
412	TOK	located		locate\VMC----
413	TOK	in		in\P
##	TAG	<name>
414	TOK	South San Francisco		South_San_Francisco\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<abbr>
415	TOK	Calif.		Calif.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
416	TOK	that		that\CS
417	TOK	it		it\RPS3N6
418	TOK	would		will\VOFDA66
419	TOK	have		have\VMI----
420	TOK	to		to\P
421	TOK	present		present\JA
422	TOK	additional		additional\JA
423	TOK	data		data\N56
424	TOK	from		from\P
425	TOK	human		human\JA
---	DLE	(		=\DELIM
426	TOK	clinical		clinical\JA
---	DLD	)		=\DELIM
427	TOK	trials		trial\N5P
428	TOK	to		to\P
429	TOK	prove		prove\VMI----
430	TOK	the		the\AT---6
431	TOK	long		long\JA
---	DLI	-		=\DELIM
432	TOK	term		term\N5S
433	TOK	safety		safety\N5S
434	TOK	of		of\P
435	TOK	its		its\APS3N6
436	TOK	monoclonal		monoclonal\JA
437	TOK	antibody		antibody\N5S
438	TOK	for		for\P
439	TOK	asthma		asthma\N5S
---	DLD	,		=\DELIM
##	TAG	<name>
440	TOK	Xolair		Xolair\N46
##	TAG	</name>
---	DLE	,		=\DELIM
441	TOK	which		which\RW63N-
442	TOK	mops		mop\VMFDRS3
443	TOK	up		up\P
444	TOK	the		the\AT---6
445	TOK	antibodies		antibody\N5P
446	TOK	that		that\RW63N6
447	TOK	play		play\VMF6R66
448	TOK	a		a\AI---S
449	TOK	role		role\N5S
450	TOK	in		in\P
451	TOK	asthma		asthma\N5S
452	TOK	and		and\CC
453	TOK	allergies		allergy\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
454	TOK	Some	BOS	some\AG---6
455	TOK	observers		observer\N5P
456	TOK	have		have\V6F6R66
457	TOK	interpreted		interpret\VMC----
458	TOK	the		the\AT---6
459	TOK	move		move\N5S
460	TOK	as		as\P
461	TOK	an		an\AI---S
462	TOK	indication		indication\N5S
463	TOK	that		that\CS
464	TOK	the		the\AT---6
##	TAG	<name>
465	TOK	FDA		FDA\N46
##	TAG	</name>
466	TOK	might		may\VOFDR66
467	TOK	be		be\VMI----
468	TOK	particularly		particularly\DGA7
469	TOK	rigorous		rigorous\JA
470	TOK	in		in\P
471	TOK	scrutinizing		scrutinize\VMG----
472	TOK	the		the\AT---6
473	TOK	side		side\N5S
474	TOK	effects		effect\N5P
475	TOK	of		of\P
476	TOK	monoclonal		monoclonal\JA
477	TOK	antibodies		antibody\N5P
---	DLD	,		=\DELIM
478	TOK	especially		especially\DGA7
479	TOK	those		that\RDP3N-
480	TOK	that		that\RW63N6
481	TOK	patients		patient\N5P
482	TOK	would		will\VOFDA66
483	TOK	take		take\VMI----
484	TOK	for		for\P
485	TOK	years		year\N5P
486	TOK	for		for\P
487	TOK	chronic		chronic\JA
488	TOK	conditions		condition\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
489	TOK	The	BOS	the\AT---6
490	TOK	announcement		announcement\N5S
491	TOK	sent		send\VMC----
492	TOK	a		a\AI---S
493	TOK	brief		brief\JA
494	TOK	chill		chill\N5S
495	TOK	through		through\P
496	TOK	investors		investor\N5P
---	DLD	,		=\DELIM
497	TOK	who		who\RW63N-
498	TOK	drove		drive\VMF6A66
499	TOK	down		down\DGA7
500	TOK	the		the\AT---6
501	TOK	stocks		stock\N5P
502	TOK	of		of\P
503	TOK	monoclonal		monoclonal\JA
504	TOK	developers		developer\N5P
505	TOK	for		for\P
506	TOK	a		a\AI---S
507	TOK	week		week\N5S
508	TOK	or		or\CC
509	TOK	so		so\RI-3N-
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
510	TOK	Nevertheless	BOS	nevertheless\DGA7
---	DLD	,		=\DELIM
511	TOK	the		the\AT---6
512	TOK	advantages		advantage\N5P
513	TOK	of		of\P
514	TOK	monoclonals		monoclonal\N5P
515	TOK	are		be\V6FDR66
516	TOK	hard		hard\JA
517	TOK	to		to\P
518	TOK	ignore		ignore\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
519	TOK	Donald L. Drakeman	BOS	Donald_L._Drakeman\N46
##	TAG	</name>
---	DLE	,		=\DELIM
520	TOK	president		president\N5S
521	TOK	and		and\CC
##	TAG	<name>
522	TOK	CEO		CEO\N46
##	TAG	</name>
523	TOK	of		of\P
524	TOK	monoclonal		monoclonal\JA
525	TOK	maker		maker\N5S
##	TAG	<name>
526	TOK	Medarex		Medarex\N46
##	TAG	</name>
527	TOK	in		in\P
##	TAG	<name>
528	TOK	Princeton		Princeton\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<abbr>
529	TOK	N.J.		N.J.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
530	TOK	says		say\VMFDRS3
531	TOK	that		that\CS
532	TOK	antibodies		antibody\N5P
533	TOK	are		be\V6FDR66
534	TOK	simply		simply\DGA7
535	TOK	easier		easy\JC
536	TOK	to		to\P
537	TOK	develop		develop\VMI----
538	TOK	than		than\CS
539	TOK	traditional		traditional\JA
540	TOK	drugs		drug\N5P
541	TOK	composed		compose\VMC----
542	TOK	of		of\P
543	TOK	small		small\JA
---	DLD	,		=\DELIM
544	TOK	inorganic		inorganic\JA
545	TOK	molecules		molecule\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
546	TOK	Because	BOS	because\CS
547	TOK	they		they\RPP3NN
548	TOK	are		be\V6FDR66
549	TOK	large		large\JA
550	TOK	molecules		molecule\N5P
---	DLD	,		=\DELIM
551	TOK	they		they\RPP3NN
552	TOK	might		may\VOFDR66
553	TOK	not		not\DGA7
554	TOK	be		be\VMI----
555	TOK	suitable		suitable\JA
556	TOK	for		for\P
557	TOK	every		every\AG---S
558	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
559	TOK	but		but\CC
560	TOK	he		he\RPS3MN
561	TOK	emphasizes		emphasize\VMFDRS3
562	TOK	that		that\CS
563	TOK	it		it\RPS3N6
564	TOK	takes		take\VMFDRS3
565	TOK	only		only\DGA7
566	TOK	one		one\MCS
567	TOK	or		or\CC
##	TAG	<num>
568	TOK	two		two\X
##	TAG	</num>
569	TOK	years		year\N5P
570	TOK	to		to\P
571	TOK	come		come\VMI----
572	TOK	up		up\P
573	TOK	with		with\P
574	TOK	a		a\AI---S
575	TOK	monoclonal		monoclonal\JA
576	TOK	antibody		antibody\N5S
577	TOK	suitable		suitable\JA
578	TOK	for		for\P
579	TOK	testing		test\VMG----
---	DLD	,		=\DELIM
##	TAG	<foreign lang="LA" pos="P">
580	TOK	versus		versus\P
##	TAG	</foreign>
581	TOK	the		the\AT---6
##	TAG	<num>
582	TOK	five		five\X
##	TAG	</num>
583	TOK	years		year\N5P
584	TOK	required		require\VMC----
585	TOK	for		for\P
586	TOK	small		small\JA
587	TOK	molecules		molecule\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
588	TOK	That	BOS	that\CS
589	TOK	speed		speed\N5S
590	TOK	translates		translate\VMFDRS3
591	TOK	into		into\P
592	TOK	savings		saving\N5P
---	DLD	:		=\DELIM
593	TOK	it		it\RPS3N6
594	TOK	costs		cost\VMFDRS3
595	TOK	only		only\DGA7
596	TOK	$		$\N5P
##	TAG	<num>
597	TOK	2 million		2_million\X
##	TAG	</num>
598	TOK	to		to\P
599	TOK	ready		ready\JA
600	TOK	a		a\AI---S
601	TOK	monoclonal		monoclonal\JA
602	TOK	antibody		antibody\N5S
603	TOK	for		for\P
604	TOK	clinical		clinical\JA
605	TOK	testing		test\VMG----
---	DLD	,		=\DELIM
##	TAG	<name>
606	TOK	Drakeman		Drakeman\N46
##	TAG	</name>
607	TOK	estimates		estimate\VMFDRS3
---	DLD	,		=\DELIM
608	TOK	compared		compare\VMC----
609	TOK	with		with\P
610	TOK	$		$\N5P
##	TAG	<num>
611	TOK	20 million		20_million\X
##	TAG	</num>
612	TOK	for		for\P
613	TOK	a		a\AI---S
614	TOK	traditional		traditional\JA
615	TOK	drug		drug\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
616	TOK	And	BOS	and\CC
617	TOK	despite		despite\P
618	TOK	the		the\AT---6
##	TAG	<name>
619	TOK	FDA		FDA\N46
##	TAG	</name>
620	PGR	's		genmark\GENMARK
621	TOK	hesitancy		hesitancy\N5S
622	TOK	to		to\P
623	TOK	approve		approve\VMI----
##	TAG	<name>
624	TOK	Genentech		Genentech\N46
##	TAG	</name>
625	PGR	's		genmark\GENMARK
626	TOK	asthma		asthma\N5S
627	TOK	therapy		therapy\N5S
---	DLD	,		=\DELIM
628	TOK	he		he\RPS3MN
629	TOK	states		state\VMFDRS3
630	TOK	that		that\CS
631	TOK	monoclonals		monoclonal\N5P
632	TOK	have		have\V6F6R66
##	TAG	<loc pos="DGA7">
633	TOK	so far		so_far\DGA7
##	TAG	</loc>
634	TOK	had		have\VMC----
635	TOK	a		a\AI---S
636	TOK	higher		high\JC
637	TOK	success		success\N5S
638	TOK	rate		rate\N5S
639	TOK	than		than\CS
640	TOK	small		small\JA
---	DLI	-		=\DELIM
641	TOK	molecule		molecule\N5S
642	TOK	drugs		drug\N5P
643	TOK	in		in\P
644	TOK	clearing		clear\VMG----
645	TOK	regulatory		regulatory\JA
646	TOK	hurdles		hurdle\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
647	TOK	Antibodies		antibody\N5P
648	TOK	are		be\V6FDR66
649	TOK	almost		almost\DGA7
650	TOK	never		never\DGA7
651	TOK	toxic		toxic\JA
---	DLD	,		=\DELIM
---	DLD	"		=\DELIM
652	TOK	he		he\RPS3MN
653	TOK	explains		explain\VMFDRS3
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
654	TOK	Ironically	BOS	ironically\DGA7
---	DLD	,		=\DELIM
655	TOK	monoclonals		monoclonal\N5P
656	TOK	might		may\VOFDR66
657	TOK	be		be\VMI----
658	TOK	victims		victim\N5P
659	TOK	of		of\P
660	TOK	their		their\APP3N6
661	TOK	own		own\JA
662	TOK	success		success\N5S
---	DLD	:		=\DELIM
663	TOK	market		market\N5S
664	TOK	analysts		analyst\N5P
665	TOK	are		be\V6FDR66
666	TOK	predicting		predict\VMG----
667	TOK	that		that\CS
668	TOK	companies		company\N5P
669	TOK	won		would\VOFDR66
670	PGR	't		not\DGA7
671	TOK	have		have\VMI----
672	TOK	sufficient		sufficient\JA
673	TOK	production		production\N5S
674	TOK	facilities		facility\N5P
675	TOK	to		to\P
676	TOK	make		make\VMI----
677	TOK	them		them\RPP3NA
678	TOK	all		all\AG---6
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
679	TOK	But	BOS	but\CC
680	TOK	the		the\AT---6
681	TOK	biotechnology		biotechnology\N5S
682	TOK	industry		industry\N5S
683	TOK	has		have\V6FDRS3
684	TOK	anticipated		anticipate\VMC----
685	TOK	this		this\AD---S
686	TOK	problem		problem\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
687	TOK	Some	BOS	some\AG---6
688	TOK	of		of\P
689	TOK	the		the\AT---6
690	TOK	more		more\DDC7
691	TOK	inventive		inventive\JA
692	TOK	proposals		proposal\N5P
693	TOK	include		include\VMF6R66
694	TOK	the		the\AT---6
695	TOK	manufacture		manufacture\N5S
696	TOK	of		of\P
697	TOK	monoclonals		monoclonal\N5P
698	TOK	in		in\P
699	TOK	the		the\AT---6
700	TOK	milk		milk\N5S
701	TOK	of		of\P
702	TOK	livestock		livestock\N5S
703	TOK	or		or\CC
704	TOK	in		in\P
705	TOK	plants		plant\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
706	TOK	Monoclonal	BOS	monoclonal\JA
##	TAG	<name>
707	TOK	Methods	EOS	Methods\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
709	TOK	The	BOS	the\AT---6
710	TOK	past		past\JA
711	TOK	failure		failure\N5S
712	TOK	of		of\P
713	TOK	monoclonals		monoclonal\N5P
714	TOK	stemmed		stem\VMF6A66
715	TOK	in		in\P
716	TOK	part		part\N5S
717	TOK	from		from\P
718	TOK	the		the\AT---6
719	TOK	way		way\N5S
720	TOK	they		they\RPP3NN
721	TOK	were		be\V6F-A66
722	TOK	originally		originally\DGA7
723	TOK	made		make\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
724	TOK	The	BOS	the\AT---6
725	TOK	classic		classic\JA
726	TOK	manufacturing		manufacturing\N5S
727	TOK	technique		technique\N5S
728	TOK	was		be\V6F-A66
729	TOK	devised		devise\VMC----
730	TOK	in		in\P
##	TAG	<num>
731	TOK	1975		1975\X
##	TAG	</num>
732	TOK	by		by\P
733	TOK	immunologists		immunologist\N5P
##	TAG	<name>
734	TOK	Georges J. F. Kohler		Georges_J._F._Kohler\N46
##	TAG	</name>
735	TOK	and		and\CC
##	TAG	<name>
736	TOK	Cesar Milstein		Cesar_Milstein\N46
##	TAG	</name>
737	TOK	of		of\P
738	TOK	the		the\AT---6
##	TAG	<name>
739	TOK	Medical Research Council		Medical_Research_Council\N46
##	TAG	</name>
740	PGR	's		genmark\GENMARK
##	TAG	<name>
741	TOK	Laboratory of Molecular Biology		Laboratory_of_Molecular_Biology\N46
##	TAG	</name>
742	TOK	in		in\P
##	TAG	<name>
743	TOK	Cambridge		Cambridge\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<name>
744	TOK	England		England\N46
##	TAG	</name>
---	DLE	,		=\DELIM
745	TOK	who		who\RW63N-
746	TOK	were		be\V6F-A66
747	TOK	awarded		award\VMC----
748	TOK	the		the\AT---6
##	TAG	<num>
749	TOK	1984		1984\X
##	TAG	</num>
##	TAG	<name>
750	TOK	Nobel Prize		Nobel_Prize\N46
##	TAG	</name>
751	TOK	in		in\P
##	TAG	<name>
752	TOK	Physiology		Physiology\N46
##	TAG	</name>
753	TOK	or		or\CC
##	TAG	<name>
754	TOK	Medicine		Medicine\N46
##	TAG	</name>
755	TOK	for		for\P
756	TOK	their		their\APP3N6
757	TOK	innovation		innovation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
758	TOK	The	BOS	the\AT---6
759	TOK	basic		basic\JA
760	TOK	process		process\N5S
761	TOK	involves		involve\VMFDRS3
762	TOK	injecting		inject\VMG----
763	TOK	an		an\AI---S
764	TOK	antigen		antigen\N5S
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
765	TOK	a		a\AI---S
766	TOK	substance		substance\N5S
767	TOK	the		the\AT---6
768	TOK	immune		immune\JA
769	TOK	system		system\N5S
770	TOK	recognizes		recognize\VMFDRS3
771	TOK	as		as\CS
772	TOK	foreign		foreign\JA
773	TOK	or		or\CC
774	TOK	dangerous		dangerous\JA
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
775	TOK	into		into\P
776	TOK	a		a\AI---S
777	TOK	mouse		mouse\N5S
---	DLD	,		=\DELIM
778	TOK	thereby		thereby\DGA7
779	TOK	inducing		induce\VMG----
780	TOK	the		the\AT---6
781	TOK	mouse		mouse\N5S
782	PGR	's		genmark\GENMARK
783	TOK	antibody		antibody\N5S
---	DLI	-		=\DELIM
784	TOK	producing		produce\VMG----
785	TOK	cells		cell\N5P
---	DLD	,		=\DELIM
786	TOK	called		call\VMC----
787	TOK	B		b\N5S
788	TOK	lymphocytes		lymphocyte\N5P
---	DLD	,		=\DELIM
789	TOK	to		to\P
790	TOK	produce		produce\VMI----
791	TOK	antibodies		antibody\N5P
792	TOK	to		to\P
793	TOK	that		that\AD---S
794	TOK	antigen		antigen\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
795	TOK	To	BOS	to\P
796	TOK	harvest		harvest\VMI----
797	TOK	such		such\JA
798	TOK	antibodies		antibody\N5P
---	DLD	,		=\DELIM
799	TOK	scientists		scientist\N5P
800	TOK	would		will\VOFDA66
801	TOK	ideally		ideally\DGA7
802	TOK	pluck		pluck\VMI----
803	TOK	only		only\DGA7
804	TOK	the		the\AT---6
805	TOK	B		b\N5S
806	TOK	cells		cell\N5P
807	TOK	that		that\RW63N6
808	TOK	make		make\VMF6R66
809	TOK	them		them\RPP3NA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
810	TOK	But	BOS	but\CC
811	TOK	finding		find\VMG----
812	TOK	the		the\AT---6
813	TOK	cells		cell\N5P
814	TOK	and		and\CC
815	TOK	getting		get\VMG----
816	TOK	them		them\RPP3NA
817	TOK	to		to\P
818	TOK	make		make\VMI----
819	TOK	large		large\JA
820	TOK	quantities		quantity\N5P
821	TOK	of		of\P
822	TOK	the		the\AT---6
823	TOK	antibodies		antibody\N5P
824	TOK	takes		take\VMFDRS3
825	TOK	some		some\AG---6
826	TOK	doing		do\VMG----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
827	TOK	Part	BOS	part\N5S
828	TOK	of		of\P
829	TOK	the		the\AT---6
830	TOK	complex		complex\JA
831	TOK	procedure		procedure\N5S
832	TOK	involves		involve\VMFDRS3
833	TOK	fusing		fuse\VMG----
834	TOK	B		b\N5S
835	TOK	cells		cell\N5P
836	TOK	from		from\P
837	TOK	the		the\AT---6
838	TOK	mice		mouse\N5P
839	TOK	to		to\P
840	TOK	immortalized		immortalize\VMF6A66
---	DLE	(		=\DELIM
841	TOK	endlessly		endlessly\DGA7
842	TOK	replicating		replicate\VMG----
---	DLD	)		=\DELIM
843	TOK	cells		cell\N5P
844	TOK	in		in\P
845	TOK	culture		culture\N5S
846	TOK	to		to\P
847	TOK	create		create\VMI----
848	TOK	cells		cell\N5P
849	TOK	called		call\VMC----
850	TOK	hybridomas		hybridoma\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
851	TOK	The	BOS	the\AT---6
852	TOK	drawback		drawback\N5S
853	TOK	of		of\P
854	TOK	these		this\AD---P
855	TOK	particular		particular\JA
856	TOK	hybridomas		hybridoma\N5P
857	TOK	is		be\V6FDRS3
858	TOK	that		that\CS
859	TOK	they		they\RPP3NN
860	TOK	produce		produce\VMF6R66
861	TOK	murine		murine\JA
862	TOK	antibodies		antibody\N5P
---	DLD	,		=\DELIM
863	TOK	which		which\RW63N-
864	TOK	the		the\AT---6
865	TOK	human		human\JA
866	TOK	immune		immune\JA
867	TOK	system		system\N5S
868	TOK	can		can\VOFDR66
869	TOK	perceive		perceive\VMI----
870	TOK	as		as\P
871	TOK	interlopers		interloper\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
872	TOK	Patients	BOS	patient\N5P
873	TOK	who		who\RW63N-
874	TOK	have		have\V6F6R66
875	TOK	received		receive\VMC----
876	TOK	infusions		infusion\N5P
877	TOK	of		of\P
878	TOK	murine		murine\JA
879	TOK	monoclonals		monoclonal\N5P
880	TOK	have		have\V6F6R66
881	TOK	experienced		experience\VMC----
882	TOK	a		a\AI---S
883	TOK	so		so\DGA7
---	DLI	-		=\DELIM
884	TOK	called		call\VMC----
##	TAG	<name>
885	TOK	HAMA		HAMA\N46
##	TAG	</name>
886	TOK	response		response\N5S
---	DLD	,		=\DELIM
887	TOK	named		name\VMC----
888	TOK	for		for\P
889	TOK	the		the\AT---6
890	TOK	human		human\JA
891	TOK	anti		anti\JA
---	DLI	-		=\DELIM
892	TOK	mouse		mouse\N5S
893	TOK	antibodies		antibody\N5P
894	TOK	they		they\RPP3NN
895	TOK	generate		generate\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
896	TOK	The	BOS	the\AT---6
##	TAG	<name>
897	TOK	HAMA		HAMA\N46
##	TAG	</name>
898	TOK	response		response\N5S
899	TOK	includes		include\VMFDRS3
900	TOK	joint		joint\N5S
901	TOK	swelling		swell\VMG----
---	DLD	,		=\DELIM
902	TOK	rashes		rash\N5P
903	TOK	and		and\CC
904	TOK	kidney		kidney\N5S
905	TOK	failure		failure\N5S
906	TOK	and		and\CC
907	TOK	can		can\VOFDR66
908	TOK	be		be\VMI----
909	TOK	life		life\N5S
---	DLI	-		=\DELIM
910	TOK	threatening		threaten\VMG----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
911	TOK	It	BOS	it\RPS3N6
912	TOK	also		also\DGA7
913	TOK	destroys		destroy\VMFDRS3
914	TOK	the		the\AT---6
915	TOK	antibodies		antibody\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
916	TOK	To	BOS	to\P
917	TOK	avoid		avoid\VMI----
918	TOK	both		both\RIP3N-
919	TOK	the		the\AT---6
##	TAG	<name>
920	TOK	HAMA		HAMA\N46
##	TAG	</name>
921	TOK	response		response\N5S
922	TOK	and		and\CC
923	TOK	the		the\AT---6
924	TOK	premature		premature\JA
925	TOK	inactivation		inactivation\N5S
926	TOK	of		of\P
927	TOK	mouse		mouse\N5S
928	TOK	antibodies		antibody\N5P
929	TOK	by		by\P
930	TOK	the		the\AT---6
931	TOK	immune		immune\JA
932	TOK	system		system\N5S
---	DLD	,		=\DELIM
933	TOK	scientists		scientist\N5P
934	TOK	have		have\V6F6R66
935	TOK	developed		develop\VMC----
936	TOK	a		a\AI---S
937	TOK	variety		variety\N5S
938	TOK	of		of\P
939	TOK	techniques		technique\N5P
940	TOK	to		to\P
941	TOK	make		make\VMI----
942	TOK	murine		murine\JA
943	TOK	antibodies		antibody\N5P
944	TOK	more		more\DDC7
945	TOK	human		human\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
946	TOK	Antibodies	BOS	antibody\N5P
947	TOK	are		be\V6FDR66
##	TAG	<name>
948	TOK	Y-shaped		Y-shaped\N46
##	TAG	</name>
949	TOK	molecules		molecule\N5P
950	TOK	that		that\RW63N6
951	TOK	bind		bind\VMF6R66
952	TOK	to		to\P
953	TOK	antigens		antigen\N5P
954	TOK	through		through\P
955	TOK	the		the\AT---6
956	TOK	arms		arm\N56
---	DLD	,		=\DELIM
957	TOK	or		or\CC
##	TAG	<name>
958	TOK	FAb		FAb\N46
##	TAG	</name>
959	TOK	regions		region\N5P
---	DLD	,		=\DELIM
960	TOK	of		of\P
961	TOK	that		that\CS
962	TOK	Y		Y\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
963	TOK	The	BOS	the\AT---6
964	TOK	stem		stem\N5S
965	TOK	of		of\P
966	TOK	the		the\AT---6
967	TOK	Y		Y\N5P
---	DLD	,		=\DELIM
968	TOK	the		the\AT---6
##	TAG	<name>
969	TOK	Fc		Fc\N46
##	TAG	</name>
970	TOK	region		region\N5S
---	DLD	,		=\DELIM
971	TOK	interacts		interact\VMFDRS3
972	TOK	with		with\P
973	TOK	cells		cell\N5P
974	TOK	of		of\P
975	TOK	the		the\AT---6
976	TOK	immune		immune\JA
977	TOK	system		system\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
978	TOK	The	BOS	the\AT---6
##	TAG	<name>
979	TOK	Fc		Fc\N46
##	TAG	</name>
980	TOK	region		region\N5S
981	TOK	is		be\V6FDRS3
982	TOK	particularly		particularly\DGA7
983	TOK	important		important\JA
984	TOK	in		in\P
985	TOK	eradicating		eradicate\VMG----
986	TOK	bacteria		bacteria\N5P
---	DLD	:		=\DELIM
987	TOK	once		once\DGA7
988	TOK	antibodies		antibody\N5P
989	TOK	coat		coat\VMF6R66
990	TOK	a		a\AI---S
991	TOK	bacterium		bacterium\N5S
992	TOK	by		by\P
993	TOK	binding		binding\N5S
994	TOK	to		to\P
995	TOK	it		it\RPS3N6
996	TOK	through		through\P
997	TOK	their		their\APP3N6
##	TAG	<name>
998	TOK	FAb		FAb\N46
##	TAG	</name>
999	TOK	regions		region\N5P
---	DLD	,		=\DELIM
1000	TOK	the		the\AT---6
##	TAG	<name>
1001	TOK	Fc		Fc\N46
##	TAG	</name>
1002	TOK	regions		region\N5P
1003	TOK	attract		attract\VMF6R66
1004	TOK	microbe		microbe\N5S
---	DLI	-		=\DELIM
1005	TOK	engulfing		engulf\VMG----
1006	TOK	cells		cell\N5P
1007	TOK	to		to\P
1008	TOK	destroy		destroy\VMI----
1009	TOK	it		it\RPS3N6
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1010	TOK	One	BOS	one\MCS
1011	TOK	approach		approach\N5S
1012	TOK	involves		involve\VMFDRS3
1013	TOK	replacing		replace\VMG----
1014	TOK	all		all\N56
1015	TOK	but		but\CC
1016	TOK	the		the\AT---6
1017	TOK	antigen		antigen\N5S
---	DLI	-		=\DELIM
1018	TOK	binding		binding\N5S
1019	TOK	regions		region\N5P
1020	TOK	of		of\P
1021	TOK	murine		murine\JA
1022	TOK	monoclonals		monoclonal\N5P
1023	TOK	with		with\P
1024	TOK	human		human\JA
1025	TOK	components		component\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
1026	TOK	Four	BOS	Four\X
##	TAG	</num>
1027	TOK	of		of\P
1028	TOK	the		the\AT---6
1029	TOK	monoclonals		monoclonal\N5P
1030	TOK	now		now\DGA7
1031	TOK	for		for\P
1032	TOK	sale		sale\N5S
1033	TOK	in		in\P
1034	TOK	the		the\AT---6
##	TAG	<abbr>
1035	TOK	U.S.		U.S.\N5P
##	TAG	</abbr>
1036	TOK	are		be\V6FDR66
1037	TOK	such		such\JA
1038	TOK	chimeric		chimeric\JA
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1039	TOK	part		part\N5S
1040	TOK	mouse		mouse\N5S
---	DLD	,		=\DELIM
1041	TOK	part		part\N5S
1042	TOK	human		human\JA
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1043	TOK	antibodies		antibody\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1044	TOK	Among	BOS	among\P
1045	TOK	them		them\RPP3NA
1046	TOK	is		be\V6FDRS3
##	TAG	<name>
1047	TOK	ReoPro		ReoPro\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1048	TOK	made		make\VMC----
1049	TOK	by		by\P
##	TAG	<name>
1050	TOK	Centocor		Centocor\N46
##	TAG	</name>
1051	TOK	in		in\P
##	TAG	<name>
1052	TOK	Malvern		Malvern\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<abbr>
1053	TOK	Pa.		Pa.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
1054	TOK	which		which\RW63N-
1055	TOK	prevents		prevent\VMFDRS3
1056	TOK	blood		blood\N5S
1057	TOK	clots		clot\N5P
1058	TOK	by		by\P
1059	TOK	binding		binding\N5S
1060	TOK	to		to\P
1061	TOK	a		a\AI---S
1062	TOK	specific		specific\JA
1063	TOK	receptor		receptor\N5S
1064	TOK	on		on\P
1065	TOK	platelets		platelet\N5P
---	DLD	;		=\DELIM
1066	TOK	it		it\RPS3N6
1067	TOK	had		have\V6F6A66
1068	TOK	sales		sale\N5P
1069	TOK	last		last\JA
1070	TOK	year		year\N5S
1071	TOK	of		of\P
1072	TOK	$		$\N5P
##	TAG	<num>
1073	TOK	418		418\X
##	TAG	</num>
##	TAG	<abbr>
1074	TOK	million.		million.\N5P
##	TAG	</abbr>
---	DLE	(		=\DELIM
1075	TOK	The		The\N5S
1076	TOK	body		body\N5S
1077	TOK	usually		usually\DGA7
1078	TOK	doesn		do\V6FDRS3
1079	PGR	't		not\DGA7
1080	TOK	make		make\VMF6R66
1081	TOK	antibodies		antibody\N5P
1082	TOK	targeted		target\VMC----
1083	TOK	to		to\P
1084	TOK	healthy		healthy\JA
1085	TOK	tissues		tissue\N5P
---	DLD	,		=\DELIM
1086	TOK	or		or\CC
1087	TOK	autoimmune		autoimmune\JA
1088	TOK	disease		disease\N5S
1089	TOK	would		will\VOFDA66
1090	TOK	result		result\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1091	TOK	But	BOS	but\CC
1092	TOK	such		such\JA
1093	TOK	antibodies		antibody\N5P
---	DLD	,		=\DELIM
1094	TOK	delivered		deliver\VMC----
1095	TOK	as		as\P
1096	TOK	drugs		drug\N5P
---	DLD	,		=\DELIM
1097	TOK	can		can\VOFDR66
1098	TOK	help		help\VMI----
1099	TOK	treat		treat\VMI----
1100	TOK	certain		certain\JA
##	TAG	<abbr>
1101	TOK	disorders.		disorders.\N5P
##	TAG	</abbr>
---	DLE	)		=\DELIM
1102	TOK	Another		Another\N5S
1103	TOK	strategy		strategy\N5S
---	DLD	,		=\DELIM
1104	TOK	called		call\VMC----
1105	TOK	humanization		humanization\N5S
---	DLD	,		=\DELIM
1106	TOK	is		be\V6FDRS3
1107	TOK	behind		behind\DGA7
##	TAG	<num>
1108	TOK	five		five\X
##	TAG	</num>
1109	TOK	more		many\JC
1110	TOK	products		product\N5P
1111	TOK	on		on\P
1112	TOK	the		the\AT---6
1113	TOK	market		market\N5S
---	DLD	,		=\DELIM
1114	TOK	including		including\P
##	TAG	<name>
1115	TOK	Herceptin		Herceptin\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1116	TOK	the		the\AT---6
1117	TOK	breast		breast\N5S
1118	TOK	cancer		cancer\N5S
---	DLI	-		=\DELIM
1119	TOK	targeting		target\VMG----
1120	TOK	monoclonal		monoclonal\JA
1121	TOK	antibody		antibody\N5S
1122	TOK	developed		develop\VMC----
1123	TOK	by		by\P
##	TAG	<name>
1124	TOK	Genentech		Genentech\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1125	TOK	Humanization	BOS	humanization\N5S
1126	TOK	entails		entail\VMFDRS3
1127	TOK	using		use\VMG----
1128	TOK	genetic		genetic\JA
1129	TOK	engineering		engineering\N5S
1130	TOK	to		to\P
1131	TOK	selectively		selectively\DGA7
1132	TOK	replace		replace\VMI----
1133	TOK	as		as\DGA7
1134	TOK	much		much\DGA7
1135	TOK	as		as\CS
1136	TOK	possible		possible\JA
1137	TOK	of		of\P
1138	TOK	the		the\AT---6
1139	TOK	murine		murine\JA
1140	TOK	antibodies		antibody\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1141	TOK	including		including\P
1142	TOK	much		much\DGA7
1143	TOK	of		of\P
1144	TOK	their		their\APP3N6
1145	TOK	antigen		antigen\N5S
---	DLI	-		=\DELIM
1146	TOK	binding		binding\N5S
1147	TOK	regions		region\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1148	TOK	with		with\P
1149	TOK	human		human\JA
1150	TOK	protein		protein\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1151	TOK	After	BOS	after\P
1152	TOK	more		more\DDC7
1153	TOK	than		than\CS
##	TAG	<num>
1154	TOK	25		25\X
##	TAG	</num>
1155	TOK	years		year\N5P
1156	TOK	of		of\P
1157	TOK	trying		try\VMG----
---	DLD	,		=\DELIM
1158	TOK	researchers		researcher\N5P
1159	TOK	have		have\V6F6R66
1160	TOK	also		also\DGA7
1161	TOK	finally		finally\DGA7
1162	TOK	fused		fuse\VMC----
1163	TOK	human		human\JA
1164	TOK	B		b\N5S
1165	TOK	cells		cell\N5P
1166	TOK	to		to\P
1167	TOK	immortalized		immortalize\VMC----
1168	TOK	cells		cell\N5P
1169	TOK	to		to\P
1170	TOK	create		create\VMI----
1171	TOK	hybridomas		hybridoma\N5P
1172	TOK	that		that\RW63N6
1173	TOK	generate		generate\VMF6R66
1174	TOK	fully		fully\DGA7
1175	TOK	human		human\JA
1176	TOK	antibodies		antibody\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1177	TOK	In	BOS	in\P
##	TAG	<loc pos="N5S">
1178	TOK	February		february\N5S
##	TAG	</loc>
---	DLE	,		=\DELIM
##	TAG	<name>
1179	TOK	Abraham Karpas		Abraham_Karpas\N46
##	TAG	</name>
1180	TOK	of		of\P
1181	TOK	the		the\AT---6
##	TAG	<name pos="N46" type="organization">
1182	TOK	University of Cambridge		University_of_Cambridge\N46
##	TAG	</name>
1183	TOK	and		and\CC
1184	TOK	his		his\APS3M6
1185	TOK	colleagues		colleague\N5P
1186	TOK	reported		report\VMC----
1187	TOK	accomplishing		accomplish\VMG----
1188	TOK	the		the\AT---6
1189	TOK	feat		feat\JA
---	DLD	,		=\DELIM
1190	TOK	although		although\CS
1191	TOK	it		it\RPS3N6
1192	TOK	is		be\V6FDRS3
##	TAG	<loc pos="DDA7">
1193	TOK	too soon		too_soon\DDA7
##	TAG	</loc>
1194	TOK	to		to\P
1195	TOK	tell		tell\VMI----
1196	TOK	whether		whether\CS
1197	TOK	the		the\AT---6
1198	TOK	monoclonals		monoclonal\N5P
1199	TOK	made		make\VMC----
1200	TOK	using		use\VMG----
1201	TOK	human		human\JA
1202	TOK	cells		cell\N5P
1203	TOK	will		will\VOFDR66
1204	TOK	be		be\VMI----
1205	TOK	safer		safe\JC
---	DLD	,		=\DELIM
1206	TOK	more		more\DDC7
1207	TOK	effective		effective\JA
1208	TOK	or		or\CC
1209	TOK	cheaper		cheap\JC
1210	TOK	to		to\P
1211	TOK	manufacture		manufacture\VMI----
1212	TOK	than		than\CS
1213	TOK	those		that\RDP3N-
1214	TOK	generated		generate\VMC----
1215	TOK	using		use\VMG----
1216	TOK	other		other\JA
1217	TOK	technologies		technology\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
1218	TOK	Medarex	BOS	Medarex\N46
##	TAG	</name>
1219	TOK	and		and\CC
##	TAG	<name>
1220	TOK	Fremont		Fremont\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<name>
1221	TOK	Calif.-based Abgenix		Calif.-based_Abgenix\N46
##	TAG	</name>
1222	TOK	have		have\V6F6R66
1223	TOK	devised		devise\VMC----
1224	TOK	ways		way\N5P
1225	TOK	to		to\P
1226	TOK	induce		induce\VMI----
1227	TOK	mice		mouse\N5P
1228	TOK	to		to\P
1229	TOK	produce		produce\VMI----
1230	TOK	fully		fully\DGA7
1231	TOK	human		human\JA
1232	TOK	antibodies		antibody\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1233	TOK	The	BOS	the\AT---6
1234	TOK	companies		company\N5P
1235	TOK	genetically		genetically\DGA7
1236	TOK	alter		alter\VMF6R66
1237	TOK	the		the\AT---6
1238	TOK	mice		mouse\N5P
1239	TOK	to		to\P
1240	TOK	contain		contain\VMI----
1241	TOK	human		human\JA
1242	TOK	antibody		antibody\N5S
1243	TOK	genes		gene\N5P
---	DLD	;		=\DELIM
1244	TOK	when		when\CS
1245	TOK	they		they\RPP3NN
1246	TOK	inject		inject\VMF6R66
1247	TOK	the		the\AT---6
1248	TOK	mice		mouse\N5P
1249	TOK	with		with\P
1250	TOK	antigens		antigen\N5P
---	DLD	,		=\DELIM
1251	TOK	the		the\AT---6
1252	TOK	animals		animal\N5P
1253	TOK	produce		produce\VMF6R66
1254	TOK	antibodies		antibody\N5P
1255	TOK	that		that\RW63N6
1256	TOK	are		be\V6FDR66
1257	TOK	human		human\JA
1258	TOK	in		in\P
1259	TOK	every		every\AG---S
1260	TOK	way		way\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
1261	TOK	The		the\AT---6
1262	TOK	technology		technology\N5S
1263	TOK	to		to\P
1264	TOK	humanize		humanize\VMI----
1265	TOK	or		or\CC
1266	TOK	make		make\VMI----
1267	TOK	fully		fully\DGA7
1268	TOK	human		human\JA
1269	TOK	monoclonal		monoclonal\JA
1270	TOK	antibodies		antibody\N5P
1271	TOK	was		be\V6F-A66
1272	TOK	one		one\MCS
1273	TOK	of		of\P
1274	TOK	those		that\AD---P
1275	TOK	changes		change\N5P
1276	TOK	that		that\RW63N6
1277	TOK	made		make\VMF6A66
---	DLE	[		=\DELIM
1278	TOK	monoclonals		monoclonal\N5P
---	DLD	]		=\DELIM
1279	TOK	more		more\DDC7
1280	TOK	commercially		commercially\DGA7
1281	TOK	viable		viable\JA
---	DLD	,		=\DELIM
---	DLD	"		=\DELIM
1282	TOK	suggests		suggest\VMFDRS3
##	TAG	<name>
1283	TOK	Walter Newman		Walter_Newman\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1284	TOK	senior		senior\N5S
1285	TOK	vice		vice\N5S
1286	TOK	president		president\N5S
1287	TOK	of		of\P
1288	TOK	biotherapeutics		biotherapeutics\N5P
1289	TOK	and		and\CC
1290	TOK	nonclinical		nonclinical\JA
1291	TOK	development		development\N5S
1292	TOK	for		for\P
##	TAG	<name>
1293	TOK	Millennium Pharmaceuticals		Millennium_Pharmaceuticals\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1294	TOK	which		which\RW63N-
1295	TOK	is		be\V6FDRS3
1296	TOK	also		also\DGA7
1297	TOK	developing		develop\VMG----
1298	TOK	monoclonal		monoclonal\JA
1299	TOK	antibody		antibody\N5S
1300	TOK	therapeutics		therapeutic\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
1301	TOK	Abgenix	BOS	Abgenix\N46
##	TAG	</name>
1302	TOK	is		be\V6FDRS3
1303	TOK	conducting		conduct\VMG----
1304	TOK	clinical		clinical\JA
1305	TOK	tests		test\N5P
1306	TOK	of		of\P
1307	TOK	a		a\AI---S
1308	TOK	fully		fully\DGA7
1309	TOK	human		human\JA
1310	TOK	antibody		antibody\N5S
1311	TOK	against		against\P
1312	TOK	interleukin		interleukin\N5S
---	DLD	-		=\DELIM
##	TAG	<num>
1313	TOK	8		8\X
##	TAG	</num>
---	DLE	(		=\DELIM
##	TAG	<na type="function">
1314	TOK	IL-8		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
1315	TOK	a		a\AI---S
1316	TOK	naturally		naturally\DGA7
1317	TOK	occurring		occur\VMG----
1318	TOK	chemical		chemical\JA
1319	TOK	known		know\VMC----
1320	TOK	as		as\P
1321	TOK	a		a\AI---S
1322	TOK	cytokine		cytokine\N5S
1323	TOK	that		that\RW63N6
1324	TOK	normally		normally\DGA7
1325	TOK	activates		activate\VMFDRS3
1326	TOK	cells		cell\N5P
1327	TOK	of		of\P
1328	TOK	the		the\AT---6
1329	TOK	immune		immune\JA
1330	TOK	system		system\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1331	TOK	When	BOS	when\CS
1332	TOK	the		the\AT---6
1333	TOK	body		body\N5S
1334	TOK	produces		produce\VMFDRS3
1335	TOK	too		too\DGA7
1336	TOK	much		much\JA
##	TAG	<na type="function">
1337	TOK	IL-8		noanat\W
##	TAG	</na>
---	DLE	,		=\DELIM
1338	TOK	inflammatory		inflammatory\JA
1339	TOK	autoimmune		autoimmune\JA
1340	TOK	diseases		disease\N5P
1341	TOK	such		such\RIS3N-
1342	TOK	as		as\P
1343	TOK	rheumatoid		rheumatoid\JA
1344	TOK	arthritis		arthritis\N5S
1345	TOK	or		or\CC
1346	TOK	psoriasis		psoriasis\N5S
1347	TOK	can		can\VOFDR66
1348	TOK	result		result\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1349	TOK	Medarex	BOS	Medarex\N46
##	TAG	</name>
1350	TOK	has		have\V6FDRS3
1351	TOK	a		a\AI---S
1352	TOK	variety		variety\N5S
1353	TOK	of		of\P
1354	TOK	clinical		clinical\JA
1355	TOK	trials		trial\N5P
1356	TOK	of		of\P
1357	TOK	fully		fully\DGA7
1358	TOK	human		human\JA
1359	TOK	monoclonals		monoclonal\N5P
1360	TOK	ongoing		ongoing\JA
1361	TOK	for		for\P
1362	TOK	cancer		cancer\N5S
1363	TOK	and		and\CC
1364	TOK	autoimmune		autoimmune\JA
1365	TOK	conditions		condition\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1366	TOK	It	BOS	it\RPS3N6
1367	TOK	is		be\V6FDRS3
1368	TOK	also		also\DGA7
1369	TOK	developing		developing\JA
1370	TOK	so		so\CC
---	DLI	-		=\DELIM
1371	TOK	called		call\VMC----
1372	TOK	designer		designer\N5S
1373	TOK	antibodies		antibody\N5P
1374	TOK	that		that\RW63N6
1375	TOK	have		have\V6F6R66
1376	TOK	been		be\VMC----
1377	TOK	engineered		engineer\VMC----
1378	TOK	either		either\CC
1379	TOK	to		to\P
1380	TOK	deliver		deliver\VMI----
1381	TOK	a		a\AI---S
1382	TOK	toxin		toxin\N5S
1383	TOK	directly		directly\DGA7
1384	TOK	to		to\P
1385	TOK	a		a\AI---S
1386	TOK	diseased		diseased\JA
1387	TOK	cell		cell\N5S
1388	TOK	or		or\CC
1389	TOK	to		to\P
1390	TOK	recruit		recruit\VMI----
1391	TOK	immune		immune\JA
1392	TOK	cells		cell\N5P
1393	TOK	specifically		specifically\DGA7
1394	TOK	to		to\P
1395	TOK	attack		attack\N5S
1396	TOK	tumors		tumor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1397	TOK	Other	BOS	other\JA
1398	TOK	investigators		investigator\N5P
1399	TOK	are		be\V6FDR66
1400	TOK	attempting		attempt\VMG----
1401	TOK	to		to\P
1402	TOK	mass		mass\N5S
---	DLI	-		=\DELIM
1403	TOK	produce		produce\N5S
1404	TOK	monoclonals		monoclonal\N5P
1405	TOK	without		without\P
1406	TOK	the		the\AT---6
1407	TOK	aid		aid\N5S
1408	TOK	of		of\P
1409	TOK	mice		mouse\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1410	TOK	Cambridge Antibody Technology	BOS	Cambridge_Antibody_Technology\N46
##	TAG	</name>
1411	TOK	in		in\P
##	TAG	<name>
1412	TOK	England		England\N46
##	TAG	</name>
1413	TOK	and		and\CC
##	TAG	<name>
1414	TOK	MorphoSys AG		MorphoSys_AG\N46
##	TAG	</name>
1415	TOK	in		in\P
##	TAG	<name>
1416	TOK	Munich		Munich\N46
##	TAG	</name>
1417	TOK	are		be\V6FDR66
1418	TOK	using		use\VMG----
1419	TOK	a		a\AI---S
1420	TOK	technique		technique\N5S
1421	TOK	called		call\VMF6A66
1422	TOK	phage		phage\N5S
1423	TOK	display		display\N5S
1424	TOK	that		that\RW63N6
1425	TOK	does		do\V6FDRS3
1426	TOK	just		just\DGA7
1427	TOK	that		that\RDS3N-
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1428	TOK	and		and\CC
1429	TOK	also		also\DGA7
1430	TOK	helps		help\VMFDRS3
1431	TOK	to		to\P
1432	TOK	find		find\VMI----
1433	TOK	the		the\AT---6
1434	TOK	most		most\DDS7
1435	TOK	specific		specific\JA
1436	TOK	monoclonals		monoclonal\N5P
1437	TOK	against		against\P
1438	TOK	a		a\AI---S
1439	TOK	particular		particular\JA
1440	TOK	antigen		antigen\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1441	TOK	Phage	BOS	phage\N5S
1442	TOK	display		display\N5S
1443	TOK	takes		take\VMFDRS3
1444	TOK	advantage		advantage\N5S
1445	TOK	of		of\P
1446	TOK	a		a\AI---S
1447	TOK	long		long\DGA7
---	DLD	,		=\DELIM
1448	TOK	stringy		stringy\JA
1449	TOK	virus		virus\N5S
1450	TOK	called		call\VMF6A66
1451	TOK	a		a\AI---S
1452	TOK	filamentous		filamentous\JA
1453	TOK	phage		phage\N5S
1454	TOK	that		that\RW63N6
1455	TOK	infects		infect\VMFDRS3
1456	TOK	bacteria		bacteria\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1457	TOK	Researchers	BOS	researcher\N5P
1458	TOK	can		can\VOFDR66
1459	TOK	isolate		isolate\VMI----
##	TAG	<name>
1460	TOK	DNA		DNA\N46
##	TAG	</name>
1461	TOK	from		from\P
1462	TOK	human		human\JA
1463	TOK	B		b\N5S
1464	TOK	lymphocytes		lymphocyte\N5P
---	DLE	(		=\DELIM
1465	TOK	each		each\AG---S
1466	TOK	cell		cell\N5S
1467	TOK	of		of\P
1468	TOK	which		which\RW63N-
1469	TOK	makes		make\VMFDRS3
1470	TOK	antibodies		antibody\N5P
1471	TOK	against		against\P
1472	TOK	only		only\DGA7
1473	TOK	one		one\MCS
1474	TOK	antigen		antigen\N5S
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
1475	TOK	insert		insert\VMF6R66
1476	TOK	this		this\AD---S
##	TAG	<name>
1477	TOK	DNA		DNA\N46
##	TAG	</name>
1478	TOK	into		into\P
1479	TOK	bacteria		bacteria\N5P
1480	TOK	such		such\RIS3N-
1481	TOK	as		as\P
##	TAG	<name>
1482	TOK	Escherichia		Escherichia\N46
##	TAG	</name>
1483	TOK	coli		coli\N5P
1484	TOK	and		and\CC
1485	TOK	then		then\DGA7
1486	TOK	allow		allow\VMF6R66
1487	TOK	filamentous		filamentous\JA
1488	TOK	phages		phage\N5P
1489	TOK	to		to\P
1490	TOK	infect		infect\VMI----
1491	TOK	the		the\AT---6
1492	TOK	bacteria		bacteria\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1493	TOK	As	BOS	as\P
1494	TOK	the		the\AT---6
1495	TOK	phages		phage\N5P
1496	TOK	produce		produce\VMF6R66
1497	TOK	new		new\JA
1498	TOK	copies		copy\N5P
1499	TOK	of		of\P
1500	TOK	themselves		themselves\RXP3N-
---	DLD	,		=\DELIM
1501	TOK	they		they\RPP3NN
1502	TOK	automatically		automatically\DGA7
1503	TOK	make		make\VMF6R66
1504	TOK	the		the\AT---6
1505	TOK	proteins		protein\N5P
1506	TOK	encoded		encode\VMC----
1507	TOK	by		by\P
1508	TOK	the		the\AT---6
1509	TOK	antibody		antibody\N5S
1510	TOK	genes		gene\N5P
1511	TOK	of		of\P
1512	TOK	the		the\AT---6
1513	TOK	various		various\JA
1514	TOK	B		b\N5S
1515	TOK	lymphocytes		lymphocyte\N5P
1516	TOK	and		and\CC
1517	TOK	add		add\VMI----
1518	TOK	them		them\RPP3NA
1519	TOK	to		to\P
1520	TOK	the		the\AT---6
1521	TOK	surfaces		surface\N5P
1522	TOK	of		of\P
1523	TOK	newly		newly\DGA7
1524	TOK	forming		form\VMG----
1525	TOK	phage		phage\N5S
1526	TOK	particles		particle\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1527	TOK	Scientists	BOS	scientist\N5P
1528	TOK	can		can\VOFDR66
1529	TOK	then		then\DGA7
1530	TOK	use		use\VMI----
1531	TOK	the		the\AT---6
1532	TOK	antigen		antigen\N5S
1533	TOK	they		they\RPP3NN
1534	TOK	intend		intend\VMF6R66
1535	TOK	to		to\P
1536	TOK	target		target\VMI----
---	DLD	,		=\DELIM
1537	TOK	such		such\JA
1538	TOK	as		as\P
1539	TOK	a		a\AI---S
1540	TOK	receptor		receptor\N5S
1541	TOK	on		on\P
1542	TOK	cancer		cancer\N5S
1543	TOK	cells		cell\N5P
---	DLD	,		=\DELIM
1544	TOK	to		to\P
1545	TOK	fish		fish\N56
1546	TOK	out		out\DGA7
1547	TOK	the		the\AT---6
1548	TOK	phages		phage\N5P
1549	TOK	containing		contain\VMG----
1550	TOK	the		the\AT---6
1551	TOK	gene		gene\N5S
1552	TOK	for		for\P
1553	TOK	the		the\AT---6
1554	TOK	most		most\DDS7
1555	TOK	specific		specific\JA
1556	TOK	antibody		antibody\N5S
1557	TOK	to		to\P
1558	TOK	that		that\AD---S
1559	TOK	antigen		antigen\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1560	TOK	To	BOS	to\P
1561	TOK	produce		produce\VMI----
##	TAG	<loc pos="DDA7">
1562	TOK	a lot of		a_lot_of\DDA7
##	TAG	</loc>
1563	TOK	that		that\CS
1564	TOK	antibody		antibody\N5S
---	DLD	,		=\DELIM
1565	TOK	they		they\RPP3NN
1566	TOK	can		can\VOFDR66
1567	TOK	either		either\DGA7
1568	TOK	have		have\VMI----
1569	TOK	one		one\MCS
1570	TOK	phage		phage\N5S
1571	TOK	infect		infect\VMF6R66
1572	TOK	more		many\JC
1573	TOK	bacteria		bacteria\N5P
1574	TOK	or		or\CC
1575	TOK	insert		insert\VMF6R66
1576	TOK	the		the\AT---6
1577	TOK	antibody		antibody\N5S
1578	TOK	gene		gene\N5S
1579	TOK	into		into\P
1580	TOK	cultured		culture\VMC----
1581	TOK	cells		cell\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1582	TOK	Zeroing	BOS	zero\VMG----
1583	TOK	In		In\N5P
1584	TOK	on		on\P
1585	TOK	the		the\AT---6
##	TAG	<name>
1586	TOK	Targets	EOS	Targets\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1588	TOK	Together	BOS	together\DGA7
1589	TOK	the		the\AT---6
1590	TOK	newer		new\JC
1591	TOK	forms		form\N5P
1592	TOK	of		of\P
1593	TOK	monoclonals		monoclonal\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1594	TOK	chimeric		chimeric\JA
---	DLD	,		=\DELIM
1595	TOK	humanized		humanize\VMC----
1596	TOK	and		and\CC
1597	TOK	human		human\JA
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1598	TOK	are		be\V6FDR66
1599	TOK	looking		look\VMG----
1600	TOK	good		good\JA
1601	TOK	against		against\P
1602	TOK	an		an\AI---S
1603	TOK	array		array\N5S
1604	TOK	of		of\P
1605	TOK	diseases		disease\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
1606	TOK	Two	BOS	Two\X
##	TAG	</num>
1607	TOK	such		such\JA
1608	TOK	drugs		drug\N5P
---	DLD	,		=\DELIM
1609	TOK	if		if\CS
1610	TOK	they		they\RPP3NN
1611	TOK	pass		pass\VMF6R66
1612	TOK	muster		muster\N5S
1613	TOK	with		with\P
1614	TOK	the		the\AT---6
##	TAG	<name>
1615	TOK	FDA		FDA\N46
##	TAG	</name>
1616	TOK	this		this\AD---S
1617	TOK	year		year\N5S
1618	TOK	as		as\DGA7
1619	TOK	expected		expect\VMF6A66
---	DLD	,		=\DELIM
1620	TOK	will		will\VOFDR66
1621	TOK	finally		finally\DGA7
1622	TOK	fulfill		fulfill\VMI----
1623	TOK	the		the\AT---6
1624	TOK	dream		dream\N5S
1625	TOK	of		of\P
1626	TOK	deploying		deploy\VMG----
1627	TOK	so		so\CC
---	DLI	-		=\DELIM
1628	TOK	called		call\VMC----
1629	TOK	conjugated		conjugate\VMF6A66
1630	TOK	monoclonals		monoclonal\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
1631	TOK	ones		one\N5P
1632	TOK	that		that\RW63N6
1633	TOK	carry		carry\VMF6R66
1634	TOK	radioactive		radioactive\JA
1635	TOK	chemicals		chemical\N5P
1636	TOK	or		or\CC
1637	TOK	toxins		toxin\N5P
1638	TOK	directly		directly\DGA7
1639	TOK	to		to\P
1640	TOK	tumors		tumor\N5P
1641	TOK	as		as\P
1642	TOK	a		a\AI---S
1643	TOK	new		new\JA
1644	TOK	form		form\N5S
1645	TOK	of		of\P
1646	TOK	cancer		cancer\N5S
1647	TOK	therapy		therapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1648	TOK	Zevalin	BOS	Zevalin\N46
##	TAG	</name>
---	DLE	(		=\DELIM
1649	TOK	developed		develop\VMC----
1650	TOK	by		by\P
##	TAG	<name pos="N46" type="place">
1651	TOK	San Diego-based IDEC Pharmaceuticals		San_Diego-based_IDEC_Pharmaceuticals\N46
##	TAG	</name>
1652	TOK	and		and\CC
##	TAG	<name>
1653	TOK	Schering AG		Schering_AG\N46
##	TAG	</name>
---	DLE	)		=\DELIM
1654	TOK	and		and\CC
##	TAG	<name>
1655	TOK	Bexxar		Bexxar\N46
##	TAG	</name>
---	DLE	(		=\DELIM
1656	TOK	devised		devise\VMC----
1657	TOK	by		by\P
##	TAG	<name>
1658	TOK	Corixa		Corixa\N46
##	TAG	</name>
1659	TOK	in		in\P
##	TAG	<name>
1660	TOK	Seattle		Seattle\N46
##	TAG	</name>
1661	TOK	and		and\CC
##	TAG	<name>
1662	TOK	GlaxoSmithKline		GlaxoSmithKline\N46
##	TAG	</name>
---	DLE	)		=\DELIM
1663	TOK	both		both\RIP3N-
1664	TOK	target		target\VMI----
1665	TOK	an		an\AI---S
1666	TOK	antigen		antigen\N5S
1667	TOK	called		call\VMF6A66
##	TAG	<name>
1668	TOK	CD20		CD20\N46
##	TAG	</name>
1669	TOK	on		on\P
1670	TOK	the		the\AT---6
1671	TOK	surfaces		surface\N5P
1672	TOK	of		of\P
1673	TOK	B		b\N5S
1674	TOK	lymphocytes		lymphocyte\N5P
---	DLD	,		=\DELIM
1675	TOK	cells		cell\N5P
1676	TOK	that		that\RW63N6
1677	TOK	grow		grow\VMF6R66
1678	TOK	uncontrollably		uncontrollably\DGA7
1679	TOK	in		in\P
1680	TOK	the		the\AT---6
1681	TOK	cancer		cancer\N5S
1682	TOK	known		know\VMC----
1683	TOK	as		as\P
1684	TOK	non		non\N5P
---	DLD	-		=\DELIM
##	TAG	<name>
1685	TOK	Hodgkin		Hodgkin\N46
##	TAG	</name>
1686	PGR	's		genmark\GENMARK
1687	TOK	lymphoma		lymphoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1688	TOK	And	BOS	and\CC
1689	TOK	both		both\RIP3N-
1690	TOK	pack		pack\VMF6R66
1691	TOK	a		a\AI---S
1692	TOK	hot		hot\JA
1693	TOK	punch		punch\N5S
---	DLD	:	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1694	TOK	Zevalin	BOS	Zevalin\N46
##	TAG	</name>
1695	TOK	totes		tote\VMFDRS3
1696	TOK	an		an\AI---S
1697	TOK	isotope		isotope\N5S
1698	TOK	of		of\P
1699	TOK	yttrium		yttrium\N5S
---	DLE	(		=\DELIM
1700	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
1701	TOK	and		and\CC
##	TAG	<name>
1702	TOK	Bexxar		Bexxar\N46
##	TAG	</name>
1703	TOK	carries		carry\VMFDRS3
1704	TOK	a		a\AI---S
1705	TOK	radioactive		radioactive\JA
1706	TOK	form		form\N5S
1707	TOK	of		of\P
1708	TOK	iodine		iodine\N5S
---	DLE	(		=\DELIM
1709	TOK	xxx		noanat\W
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1711	TOK	Many	BOS	many\AI---P
1712	TOK	other		other\JA
1713	TOK	monoclonals		monoclonal\N5P
1714	TOK	now		now\DGA7
1715	TOK	in		in\P
1716	TOK	clinical		clinical\JA
1717	TOK	trials		trial\N5P
1718	TOK	also		also\DGA7
1719	TOK	target		target\N5S
1720	TOK	molecules		molecule\N5P
1721	TOK	on		on\P
1722	TOK	immune		immune\JA
1723	TOK	cells		cell\N5P
1724	TOK	that		that\RW63N6
1725	TOK	play		play\VMF6R66
1726	TOK	a		a\AI---S
1727	TOK	role		role\N5S
1728	TOK	in		in\P
1729	TOK	a		a\AI---S
1730	TOK	variety		variety\N5S
1731	TOK	of		of\P
1732	TOK	diseases		disease\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
1733	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
##	TAG	<name>
1734	TOK	Genentech		Genentech\N46
##	TAG	</name>
1735	TOK	is		be\V6FDRS3
1736	TOK	in		in\P
1737	TOK	the		the\AT---6
1738	TOK	late		late\JA
1739	TOK	stages		stage\N5P
1740	TOK	of		of\P
1741	TOK	testing		test\VMG----
##	TAG	<name>
1742	TOK	Xanelim		Xanelim\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1743	TOK	its		its\APS3N6
1744	TOK	monoclonal		monoclonal\JA
1745	TOK	against		against\P
1746	TOK	xxx		noanat\W
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1747	TOK	This	BOS	this\AD---S
1748	TOK	protein		protein\N5S
1749	TOK	exists		exist\VMFDRS3
1750	TOK	on		on\P
1751	TOK	the		the\AT---6
1752	TOK	surfaces		surface\N5P
1753	TOK	of		of\P
1754	TOK	T		t\N5S
1755	TOK	lymphocytes		lymphocyte\N5P
1756	TOK	and		and\CC
1757	TOK	helps		help\VMFDRS3
1758	TOK	them		them\RPP3NA
1759	TOK	to		to\P
1760	TOK	infiltrate		infiltrate\VMI----
1761	TOK	the		the\AT---6
1762	TOK	skin		skin\N5S
1763	TOK	and		and\CC
1764	TOK	cause		cause\VMF6R66
1765	TOK	the		the\AT---6
1766	TOK	inflammation		inflammation\N5S
1767	TOK	of		of\P
1768	TOK	psoriasis		psoriasis\N5S
---	DLD	,		=\DELIM
1769	TOK	which		which\RW63N-
1770	TOK	afflicts		afflict\VMFDRS3
1771	TOK	an		an\AI---S
1772	TOK	estimated		estimate\VMF6A66
##	TAG	<num>
1773	TOK	seven million		seven_million\X
##	TAG	</num>
1774	TOK	people		people\N56
1775	TOK	in		in\P
1776	TOK	the		the\AT---6
##	TAG	<name>
1777	TOK	U.S		U.S\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1778	TOK	In	BOS	in\P
1779	TOK	a		a\AI---S
1780	TOK	study		study\N5S
1781	TOK	of		of\P
1782	TOK	nearly		nearly\DGA7
##	TAG	<num>
1783	TOK	600		600\X
##	TAG	</num>
1784	TOK	psoriasis		psoriasis\N5S
1785	TOK	sufferers		sufferer\N5P
1786	TOK	that		that\RW63N6
1787	TOK	was		be\V6F-A66
1788	TOK	reported		report\VMC----
1789	TOK	at		at\P
1790	TOK	the		the\AT---6
##	TAG	<name>
1791	TOK	American Academy of Dermatology		American_Academy_of_Dermatology\N46
##	TAG	</name>
1792	TOK	conference		conference\N5S
1793	TOK	in		in\P
##	TAG	<loc pos="N5S">
1794	TOK	July		july\N5S
##	TAG	</loc>
---	DLE	,		=\DELIM
1795	TOK	researchers		researcher\N5P
1796	TOK	found		find\VMF6A66
1797	TOK	that		that\AD---S
##	TAG	<num>
1798	TOK	57		57\X
##	TAG	</num>
1799	TOK	percent		percent\N56
1800	TOK	of		of\P
1801	TOK	patients		patient\N5P
1802	TOK	on		on\P
1803	TOK	the		the\AT---6
1804	TOK	highest		high\JS
1805	TOK	dose		dose\N5S
1806	TOK	of		of\P
1807	TOK	the		the\AT---6
1808	TOK	drug		drug\N5S
1809	TOK	experienced		experience\VMF6A66
##	TAG	<loc pos="DGA7">
1810	TOK	at least		at_least\DGA7
##	TAG	</loc>
1811	TOK	a		a\AI---S
##	TAG	<num>
1812	TOK	50		50\X
##	TAG	</num>
1813	TOK	percent		percent\N56
1814	TOK	decrease		decrease\VMF6R66
1815	TOK	in		in\P
1816	TOK	the		the\AT---6
1817	TOK	severity		severity\N5S
1818	TOK	of		of\P
1819	TOK	their		their\APP3N6
1820	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1821	TOK	Several	BOS	several\JA
1822	TOK	companies		company\N5P
1823	TOK	are		be\V6FDR66
1824	TOK	also		also\DGA7
1825	TOK	pursuing		pursue\VMG----
1826	TOK	monoclonals		monoclonal\N5P
1827	TOK	against		against\P
##	TAG	<name>
1828	TOK	CD18		CD18\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1829	TOK	a		a\AI---S
1830	TOK	protein		protein\N5S
1831	TOK	on		on\P
1832	TOK	T		t\N5S
1833	TOK	lymphocytes		lymphocyte\N5P
1834	TOK	that		that\RW63N6
1835	TOK	underlies		underlie\VMFDRS3
1836	TOK	inflammation		inflammation\N5S
##	TAG	<loc pos="DGA7">
1837	TOK	as well as		as_well_as\DGA7
##	TAG	</loc>
1838	TOK	the		the\AT---6
1839	TOK	tissue		tissue\N5S
1840	TOK	damage		damage\N5S
1841	TOK	resulting		result\VMG----
1842	TOK	from		from\P
1843	TOK	a		a\AI---S
1844	TOK	heart		heart\N5S
1845	TOK	attack		attack\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1846	TOK	A	BOS	a\AI---S
1847	TOK	molecule		molecule\N5S
1848	TOK	called		call\VMF6A66
1849	TOK	the		the\AT---6
1850	TOK	epidermal		epidermal\JA
1851	TOK	growth		growth\N5S
1852	TOK	factor		factor\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
1853	TOK	EGF		EGF\N46
##	TAG	</name>
---	DLE	)		=\DELIM
1854	TOK	receptor		receptor\N5S
1855	TOK	is		be\V6FDRS3
1856	TOK	an		an\AI---S
1857	TOK	additional		additional\JA
1858	TOK	tempting		tempting\JA
1859	TOK	target		target\N5S
1860	TOK	for		for\P
1861	TOK	monoclonal		monoclonal\JA
1862	TOK	developers		developer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1863	TOK	One	BOS	one\MCS
1864	TOK	third		third\MOS
1865	TOK	of		of\P
1866	TOK	patients		patient\N5P
1867	TOK	with		with\P
1868	TOK	solid		solid\JA
1869	TOK	tumors		tumor\N5P
1870	TOK	make		make\VMF6R66
1871	TOK	excess		excess\N5S
##	TAG	<name pos="N46" expansion="epidermal growth factor">
1872	TOK	EGF		EGF\N46
##	TAG	</name>
1873	TOK	receptors		receptor\N5P
---	DLD	;		=\DELIM
1874	TOK	indeed		indeed\DGA7
---	DLD	,		=\DELIM
1875	TOK	the		the\AT---6
1876	TOK	much		much\DGA7
1877	TOK	heralded		herald\VMC----
1878	TOK	small		small\JA
---	DLI	-		=\DELIM
1879	TOK	molecule		molecule\N5S
1880	TOK	drug		drug\N5S
##	TAG	<name>
1881	TOK	Gleevec		Gleevec\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1882	TOK	sold		sell\VMC----
1883	TOK	by		by\P
##	TAG	<name>
1884	TOK	Novartis		Novartis\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1885	TOK	interferes		interfere\VMFDRS3
1886	TOK	with		with\P
1887	TOK	the		the\AT---6
1888	TOK	ability		ability\N5S
1889	TOK	of		of\P
1890	TOK	cancer		cancer\N5S
1891	TOK	cells		cell\N5P
1892	TOK	to		to\P
1893	TOK	receive		receive\VMI----
1894	TOK	growth		growth\N5S
1895	TOK	signals		signal\N5P
1896	TOK	from		from\P
1897	TOK	those		that\AD---P
1898	TOK	receptors		receptor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
1899	TOK	Anti-EGF	BOS	Anti-EGF\N46
##	TAG	</name>
1900	TOK	receptor		receptor\N5S
1901	TOK	monoclonals		monoclonal\N5P
1902	TOK	might		may\VOFDR66
1903	TOK	best		good\DDS7
1904	TOK	be		be\VMI----
1905	TOK	administered		administer\VMC----
1906	TOK	in		in\P
1907	TOK	combination		combination\N5S
1908	TOK	with		with\P
1909	TOK	traditional		traditional\JA
1910	TOK	chemotherapies		chemotherapy\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1911	TOK	At	BOS	at\P
1912	TOK	the		the\AT---6
##	TAG	<name>
1913	TOK	American Society of Clinical Oncology		American_Society_of_Clinical_Oncology\N46
##	TAG	</name>
1914	TOK	conference		conference\N5S
1915	TOK	in		in\P
1916	TOK	May		May\N5P
---	DLD	,		=\DELIM
1917	TOK	researchers		researcher\N5P
1918	TOK	reported		report\VMF6A66
1919	TOK	that		that\CS
1920	TOK	cetuximab		cetuximab\N5P
---	DLD	,		=\DELIM
1921	TOK	an		an\AI---S
1922	TOK	anti		anti\JA
---	DLD	-		=\DELIM
##	TAG	<name pos="N46" expansion="epidermal growth factor">
1923	TOK	EGF		EGF\N46
##	TAG	</name>
1924	TOK	receptor		receptor\N5S
1925	TOK	antibody		antibody\N5S
1926	TOK	produced		produce\VMC----
1927	TOK	by		by\P
##	TAG	<name>
1928	TOK	ImClone Systems		ImClone_Systems\N46
##	TAG	</name>
1929	TOK	in		in\P
##	TAG	<name>
1930	TOK	New York City		New_York_City\N46
##	TAG	</name>
---	DLE	,		=\DELIM
1931	TOK	helped		help\VMF6A66
1932	TOK	chemotherapy		chemotherapy\N5S
1933	TOK	to		to\P
1934	TOK	start		start\VMI----
1935	TOK	working		work\VMG----
1936	TOK	again		again\DGA7
1937	TOK	in		in\P
##	TAG	<num>
1938	TOK	23		23\X
##	TAG	</num>
1939	TOK	percent		percent\N56
1940	TOK	of		of\P
1941	TOK	patients		patient\N5P
1942	TOK	with		with\P
1943	TOK	advanced		advance\VMC----
1944	TOK	colorectal		colorectal\JA
1945	TOK	cancer		cancer\N5S
1946	TOK	who		who\RW63N-
1947	TOK	had		have\V6F6A66
1948	TOK	stopped		stop\VMC----
1949	TOK	responding		respond\VMG----
1950	TOK	to		to\P
1951	TOK	chemotherapy		chemotherapy\N5S
1952	TOK	alone		alone\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1953	TOK	Other	BOS	other\JA
1954	TOK	companies		company\N5P
1955	TOK	are		be\V6FDR66
1956	TOK	focusing		focus\VMG----
1957	TOK	on		on\P
1958	TOK	making		make\VMG----
1959	TOK	monoclonal		monoclonal\JA
1960	TOK	antibodies		antibody\N5P
1961	TOK	to		to\P
1962	TOK	molecules		molecule\N5P
1963	TOK	on		on\P
1964	TOK	the		the\AT---6
1965	TOK	surfaces		surface\N5P
1966	TOK	of		of\P
1967	TOK	the		the\AT---6
1968	TOK	cells		cell\N5P
1969	TOK	that		that\RW63N6
1970	TOK	line		line\VMF6R66
1971	TOK	the		the\AT---6
1972	TOK	blood		blood\N5S
1973	TOK	vessels		vessel\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1974	TOK	Certain	BOS	certain\JA
1975	TOK	types		type\N5P
1976	TOK	of		of\P
1977	TOK	these		this\AD---P
1978	TOK	molecules		molecule\N5P
---	DLD	,		=\DELIM
1979	TOK	such		such\JA
1980	TOK	as		as\P
1981	TOK	avb3		avb3\N5P
---	DLD	,		=\DELIM
1982	TOK	play		play\VMF6R66
1983	TOK	a		a\AI---S
1984	TOK	role		role\N5S
1985	TOK	in		in\P
1986	TOK	angiogenesis		angiogenesis\N5S
---	DLD	,		=\DELIM
1987	TOK	the		the\AT---6
1988	TOK	growth		growth\N5S
1989	TOK	of		of\P
1990	TOK	new		new\JA
1991	TOK	blood		blood\N5S
1992	TOK	vessels		vessel\N5P
---	DLD	,		=\DELIM
1993	TOK	which		which\RW63N-
1994	TOK	is		be\V6FDRS3
1995	TOK	a		a\AI---S
1996	TOK	crucial		crucial\JA
1997	TOK	step		step\N5S
1998	TOK	in		in\P
1999	TOK	the		the\AT---6
2000	TOK	development		development\N5S
2001	TOK	of		of\P
2002	TOK	tumors		tumor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2003	TOK	A	BOS	a\AI---S
2004	TOK	hugely		hugely\DGA7
2005	TOK	successful		successful\JA
2006	TOK	monoclonal		monoclonal\JA
2007	TOK	antibody		antibody\N5S
2008	TOK	drug		drug\N5S
2009	TOK	now		now\DGA7
2010	TOK	on		on\P
2011	TOK	the		the\AT---6
2012	TOK	market		market\N5S
---	DLD	,		=\DELIM
##	TAG	<name>
2013	TOK	Remicade		Remicade\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2014	TOK	targets		target\N5P
2015	TOK	tumor		tumor\N5S
2016	TOK	necrosis		necrosis\N5S
2017	TOK	factor		factor\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
2018	TOK	TNF		TNF\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
2019	TOK	a		a\AI---S
2020	TOK	molecule		molecule\N5S
2021	TOK	the		the\AT---6
2022	TOK	body		body\N5S
2023	TOK	uses		use\VMFDRS3
2024	TOK	to		to\P
2025	TOK	juice		juice\VMI----
2026	TOK	the		the\AT---6
2027	TOK	cellular		cellular\JA
2028	TOK	arm		arm\N5S
2029	TOK	of		of\P
2030	TOK	the		the\AT---6
2031	TOK	immune		immune\JA
2032	TOK	system		system\N5S
2033	TOK	but		but\CC
2034	TOK	that		that\CS
2035	TOK	also		also\DGA7
2036	TOK	plays		play\VMFDRS3
2037	TOK	a		a\AI---S
2038	TOK	role		role\N5S
2039	TOK	in		in\P
2040	TOK	inflammatory		inflammatory\JA
2041	TOK	diseases		disease\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="P">
2042	TOK	According to	BOS	According_to\P
##	TAG	</loc>
2043	TOK	company		company\N5S
2044	TOK	reports		report\VMFDRS3
---	DLD	,		=\DELIM
##	TAG	<name>
2045	TOK	Remicade		Remicade\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2046	TOK	which		which\RW63N-
2047	TOK	is		be\V6FDRS3
2048	TOK	on		on\P
2049	TOK	pharmacy		pharmacy\N5S
2050	TOK	shelves		shelf\N5P
2051	TOK	for		for\P
##	TAG	<name>
2052	TOK	Crohn		Crohn\N46
##	TAG	</name>
2053	PGR	's		genmark\GENMARK
2054	TOK	disease		disease\N5S
---	DLE	(		=\DELIM
2055	TOK	an		an\AI---S
2056	TOK	inflammatory		inflammatory\JA
2057	TOK	bowel		bowel\N5S
2058	TOK	disease		disease\N5S
---	DLD	)		=\DELIM
2059	TOK	and		and\CC
2060	TOK	rheumatoid		rheumatoid\JA
2061	TOK	arthritis		arthritis\N5S
---	DLD	,		=\DELIM
2062	TOK	made		make\VMC----
2063	TOK	$		$\N5P
##	TAG	<num>
2064	TOK	370 million		370_million\X
##	TAG	</num>
2065	TOK	last		last\JA
2066	TOK	year		year\N5S
2067	TOK	for		for\P
2068	TOK	its		its\APS3N6
2069	TOK	developer		developer\N5S
---	DLD	,		=\DELIM
##	TAG	<name>
2070	TOK	Centocor		Centocor\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2071	TOK	Therapies	BOS	therapy\N5P
2072	TOK	that		that\RW63N6
2073	TOK	wipe		wipe\VMF6R66
2074	TOK	out		out\DGA7
##	TAG	<name pos="N46" expansion="tumor necrosis factor">
2075	TOK	TNF		TNF\N46
##	TAG	</name>
2076	TOK	have		have\V6F6R66
2077	TOK	a		a\AI---S
2078	TOK	potential		potential\JA
2079	TOK	$		$\N5P
##	TAG	<num>
2080	TOK	2 billion		2_billion\X
##	TAG	</num>
---	DLE	-		=\DELIM
2081	TOK	annual		annual\JA
2082	TOK	market		market\N5S
---	DLD	,		=\DELIM
##	TAG	<loc pos="P">
2083	TOK	according to		according_to\P
##	TAG	</loc>
##	TAG	<name>
2084	TOK	Carol Werther		Carol_Werther\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2085	TOK	managing		managing\JA
2086	TOK	director		director\N5S
2087	TOK	of		of\P
2088	TOK	equity		equity\N5S
2089	TOK	research		research\N5S
2090	TOK	at		at\P
2091	TOK	the		the\AT---6
2092	TOK	investment		investment\N5S
2093	TOK	bank		bank\N5S
##	TAG	<name>
2094	TOK	Adams		Adams\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<name>
2095	TOK	Harkness		Harkness\N46
##	TAG	</name>
2096	TOK	and		and\CC
##	TAG	<abbr>
2097	TOK	Hill.		Hill.\N5P
##	TAG	</abbr>
---	DLE	(		=\DELIM
##	TAG	<name>
2098	TOK	Enbrel		Enbrel\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2099	TOK	an		an\AI---S
2100	TOK	anti		anti\JA
---	DLD	-		=\DELIM
##	TAG	<name pos="N46" expansion="tumor necrosis factor">
2101	TOK	TNF		TNF\N46
##	TAG	</name>
2102	TOK	drug		drug\N5S
2103	TOK	developed		develop\VMC----
2104	TOK	by		by\P
##	TAG	<name>
2105	TOK	Immunex		Immunex\N46
##	TAG	</name>
2106	TOK	in		in\P
##	TAG	<name>
2107	TOK	Seattle		Seattle\N46
##	TAG	</name>
2108	TOK	that		that\RW63N6
2109	TOK	was		be\V6F-A66
2110	TOK	approved		approve\VMC----
2111	TOK	in		in\P
##	TAG	<num>
2112	TOK	2000		2000\X
##	TAG	</num>
2113	TOK	for		for\P
2114	TOK	patients		patient\N5P
2115	TOK	with		with\P
2116	TOK	moderate		moderate\VMI----
2117	TOK	to		to\P
2118	TOK	severe		severe\JA
2119	TOK	rheumatoid		rheumatoid\JA
2120	TOK	arthritis		arthritis\N5S
---	DLD	,		=\DELIM
2121	TOK	is		be\V6FDRS3
2122	TOK	not		not\DGA7
2123	TOK	technically		technically\DGA7
2124	TOK	a		a\AI---S
2125	TOK	monoclonal		monoclonal\JA
2126	TOK	antibody		antibody\N5S
---	DLD	,		=\DELIM
2127	TOK	because		because\CS
2128	TOK	only		only\JA
2129	TOK	part		part\N5S
2130	TOK	of		of\P
2131	TOK	an		an\AI---S
2132	TOK	antibody		antibody\N5S
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
2133	TOK	the		the\AT---6
2134	TOK	backbone		backbone\N5S
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
2135	TOK	is		be\V6FDRS3
2136	TOK	used		use\VMC----
---	DLD	;		=\DELIM
2137	TOK	that		that\CS
2138	TOK	backbone		backbone\N5S
2139	TOK	is		be\V6FDRS3
2140	TOK	linked		link\VMC----
2141	TOK	to		to\P
2142	TOK	a		a\AI---S
2143	TOK	piece		piece\N5S
2144	TOK	of		of\P
2145	TOK	another		another\JA
2146	TOK	kind		kind\N5S
2147	TOK	of		of\P
2148	TOK	molecule		molecule\N5S
---	DLD	,		=\DELIM
2149	TOK	the		the\AT---6
2150	TOK	normal		normal\JA
2151	TOK	cellular		cellular\JA
2152	TOK	receptor		receptor\N5S
2153	TOK	for		for\P
##	TAG	<abbr>
2154	TOK	TNF.		TNF.\N5P
##	TAG	</abbr>
---	DLE	)	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2155	TOK	Emerging	BOS	Emerging\N5S
##	TAG	<name>
2156	TOK	Issues	EOS	Issues\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2158	TOK	With	BOS	with\P
2159	TOK	all		all\AG---6
2160	TOK	these		this\AD---P
2161	TOK	good		good\JA
2162	TOK	opportunities		opportunity\N5P
2163	TOK	facing		face\VMG----
2164	TOK	them		them\RPP3NA
---	DLD	,		=\DELIM
2165	TOK	biotechnology		biotechnology\N5S
2166	TOK	and		and\CC
2167	TOK	pharmaceutical		pharmaceutical\JA
2168	TOK	companies		company\N5P
2169	TOK	might		may\VOFDR66
2170	TOK	be		be\VMI----
2171	TOK	expected		expect\VMC----
2172	TOK	to		to\P
2173	TOK	be		be\VMI----
2174	TOK	ramping		ramp\VMG----
2175	TOK	up		up\P
2176	TOK	their		their\APP3N6
2177	TOK	production		production\N5S
2178	TOK	lines		line\N5P
2179	TOK	in		in\P
2180	TOK	anticipation		anticipation\N5S
2181	TOK	of		of\P
2182	TOK	a		a\AI---S
2183	TOK	big		big\JA
2184	TOK	market		market\N5S
2185	TOK	surge		surge\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2186	TOK	But	BOS	but\CC
2187	TOK	worldwide		worldwide\DGA7
2188	TOK	just		just\DGA7
##	TAG	<num>
2189	TOK	10		10\X
##	TAG	</num>
2190	TOK	large		large\JA
---	DLI	-		=\DELIM
2191	TOK	scale		scale\N5S
2192	TOK	antibody		antibody\N5S
2193	TOK	plants		plant\N5P
2194	TOK	are		be\V6FDR66
2195	TOK	now		now\DGA7
2196	TOK	operating		operate\VMG----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2197	TOK	Part	BOS	part\N5S
2198	TOK	of		of\P
2199	TOK	the		the\AT---6
2200	TOK	problem		problem\N5S
2201	TOK	is		be\V6FDRS3
2202	TOK	financial		financial\JA
---	DLD	:		=\DELIM
2203	TOK	banks		bank\N5P
2204	TOK	don		do\V6FDR66
2205	PGR	't		not\DGA7
2206	TOK	want		want\N5S
2207	TOK	to		to\P
2208	TOK	lend		lend\VMI----
2209	TOK	the		the\AT---6
2210	TOK	hundreds		hundred\N5P
2211	TOK	of		of\P
2212	TOK	millions		million\N5P
2213	TOK	of		of\P
2214	TOK	dollars		dollar\N5P
2215	TOK	it		it\RPS3N6
2216	TOK	takes		take\VMFDRS3
2217	TOK	to		to\P
2218	TOK	build		build\VMI----
2219	TOK	a		a\AI---S
2220	TOK	state		state\N5S
---	DLI	-		=\DELIM
2221	TOK	of		of\P
---	DLI	-		=\DELIM
2222	TOK	the		the\AT---6
---	DLI	-		=\DELIM
2223	TOK	art		art\N5S
2224	TOK	monoclonal		monoclonal\JA
2225	TOK	production		production\N5S
2226	TOK	facility		facility\N5S
2227	TOK	unless		unless\CS
2228	TOK	the		the\AT---6
2229	TOK	likelihood		likelihood\N5S
2230	TOK	that		that\CS
2231	TOK	the		the\AT---6
2232	TOK	plant		plant\N5S
2233	TOK	will		will\VOFDR66
2234	TOK	generate		generate\VMI----
2235	TOK	profits		profit\N5P
2236	TOK	is		be\V6FDRS3
2237	TOK	all		all\DGA7
2238	TOK	but		but\CC
2239	TOK	guaranteed		guarantee\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2240	TOK	Many	BOS	many\AI---P
2241	TOK	of		of\P
2242	TOK	them		them\RPP3NA
2243	TOK	look		look\VMI----
2244	TOK	back		back\DGA7
2245	TOK	on		on\P
2246	TOK	the		the\AT---6
##	TAG	<na type="code">
2247	TOK	1980s		noanat\W
##	TAG	</na>
---	DLE	,		=\DELIM
2248	TOK	when		when\CS
2249	TOK	drug		drug\N5S
2250	TOK	manufacturers		manufacturer\N5P
2251	TOK	built		build\VMC----
2252	TOK	facilities		facility\N5P
2253	TOK	that		that\RW63N6
2254	TOK	operated		operate\VMF6A66
2255	TOK	for		for\P
2256	TOK	years		year\N5P
2257	TOK	at		at\P
2258	TOK	only		only\DGA7
2259	TOK	partial		partial\JA
2260	TOK	capacity		capacity\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2261	TOK	The	BOS	the\AT---6
2262	TOK	gold		gold\N5S
2263	TOK	standard		standard\N5S
2264	TOK	for		for\P
2265	TOK	producing		produce\VMG----
2266	TOK	monoclonals		monoclonal\N5P
2267	TOK	from		from\P
2268	TOK	hybridomas		hybridoma\N5P
2269	TOK	relies		rely\VMFDRS3
2270	TOK	on		on\P
2271	TOK	enormous		enormous\JA
2272	TOK	tanks		tank\N5P
2273	TOK	called		call\VMC----
2274	TOK	bioreactors		bioreactor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2275	TOK	V. Bryan Lawlis	BOS	V._Bryan_Lawlis\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2276	TOK	chairman		chairman\N5S
2277	TOK	of		of\P
##	TAG	<name>
2278	TOK	Diosynth ATP		Diosynth_ATP\N46
##	TAG	</name>
2279	TOK	in		in\P
##	TAG	<name>
2280	TOK	Cary		Cary\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<abbr>
2281	TOK	N.C.		N.C.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
2282	TOK	estimates		estimate\N5P
2283	TOK	that		that\CS
2284	TOK	one		one\MCS
2285	TOK	giant		giant\N5S
---	DLD	,		=\DELIM
##	TAG	<num>
2286	TOK	60,000		60,000\X
##	TAG	</num>
---	DLE	-		=\DELIM
2287	TOK	liter		liter\N5S
2288	TOK	bioreactor		bioreactor\N5S
2289	TOK	plant		plant\N5S
2290	TOK	would		will\VOFDA66
2291	TOK	be		be\VMI----
2292	TOK	able		able\JA
2293	TOK	to		to\P
---	DLE	(		=\DELIM
2294	TOK	hypothetically		hypothetically\DGA7
---	DLD	)		=\DELIM
2295	TOK	accommodate		accommodate\VMI----
2296	TOK	only		only\DGA7
##	TAG	<num>
2297	TOK	four		four\X
##	TAG	</num>
2298	TOK	products		product\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2299	TOK	Assuming	BOS	assume\VMG----
2300	TOK	that		that\AD---S
##	TAG	<num>
2301	TOK	100		100\X
##	TAG	</num>
2302	TOK	monoclonals		monoclonal\N5P
2303	TOK	will		will\VOFDR66
2304	TOK	be		be\VMI----
2305	TOK	on		on\P
2306	TOK	the		the\AT---6
2307	TOK	market		market\N5S
2308	TOK	by		by\P
##	TAG	<num>
2309	TOK	2010		2010\X
##	TAG	</num>
---	DLE	,		=\DELIM
2310	TOK	as		as\P
2311	TOK	analysts		analyst\N5P
2312	TOK	predict		predict\VMF6R66
---	DLD	,		=\DELIM
##	TAG	<name>
2313	TOK	Lawlis		Lawlis\N46
##	TAG	</name>
2314	TOK	calculates		calculate\VMFDRS3
2315	TOK	that		that\CS
2316	TOK	the		the\AT---6
2317	TOK	industry		industry\N5S
2318	TOK	will		will\VOFDR66
2319	TOK	need		need\VMI----
2320	TOK	to		to\P
2321	TOK	build		build\VMI----
##	TAG	<loc pos="DGA7">
2322	TOK	at least		at_least\DGA7
##	TAG	</loc>
##	TAG	<num>
2323	TOK	25		25\X
##	TAG	</num>
2324	TOK	new		new\JA
2325	TOK	facilities		facility\N5P
2326	TOK	or		or\CC
---	DLE	"		=\DELIM
2327	TOK	we		we\RPP1NN
2328	TOK	can		can\V6FDR66
2329	PGR	't		not\DGA7
2330	TOK	satisfy		satisfy\VMI----
2331	TOK	all		all\AG---6
2332	TOK	the		the\AT---6
2333	TOK	needs		need\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
2334	TOK	Those		that\AD---P
2335	TOK	production		production\N5S
2336	TOK	plants		plant\N5P
2337	TOK	would		will\VOFDA66
2338	TOK	require		require\VMI----
2339	TOK	$		$\N5P
##	TAG	<num>
2340	TOK	5 billion		5_billion\X
##	TAG	</num>
2341	TOK	or		or\CC
2342	TOK	more		more\DDC7
2343	TOK	and		and\CC
2344	TOK	between		between\P
##	TAG	<num>
2345	TOK	three		three\X
##	TAG	</num>
2346	TOK	and		and\CC
##	TAG	<num>
2347	TOK	five		five\X
##	TAG	</num>
2348	TOK	years		year\N5P
2349	TOK	to		to\P
2350	TOK	be		be\VMI----
2351	TOK	built		build\VMC----
2352	TOK	and		and\CC
2353	TOK	certified		certify\VMC----
2354	TOK	by		by\P
2355	TOK	the		the\AT---6
##	TAG	<name>
2356	TOK	FDA--a		FDA--a\N46
##	TAG	</name>
2357	TOK	prospect		prospect\N5S
##	TAG	<loc pos="RIS3N-">
2358	TOK	no one		no_one\RIS3N-
##	TAG	</loc>
2359	TOK	thinks		think\VMFDRS3
2360	TOK	is		be\V6FDRS3
2361	TOK	going		go\VMG----
2362	TOK	to		to\P
2363	TOK	happen		happen\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2364	TOK	To	BOS	to\P
2365	TOK	fill		fill\VMI----
2366	TOK	the		the\AT---6
2367	TOK	void		void\JA
---	DLD	,		=\DELIM
2368	TOK	some		some\AG---6
2369	TOK	companies		company\N5P
2370	TOK	are		be\V6FDR66
2371	TOK	turning		turn\VMG----
2372	TOK	to		to\P
2373	TOK	transgenic		transgenic\JA
2374	TOK	animals		animal\N5P
2375	TOK	and		and\CC
2376	TOK	plants		plant\N5P
---	DLD	,		=\DELIM
2377	TOK	those		that\AD---P
2378	TOK	organisms		organism\N5P
2379	TOK	engineered		engineer\VMC----
2380	TOK	to		to\P
2381	TOK	carry		carry\VMI----
2382	TOK	genes		gene\N5P
2383	TOK	for		for\P
2384	TOK	selected		select\VMC----
2385	TOK	antibodies		antibody\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2386	TOK	Transgenic	BOS	transgenic\JA
2387	TOK	mammals		mammal\N5P
2388	TOK	that		that\RW63N6
2389	TOK	secrete		secrete\VMF6R66
2390	TOK	monoclonals		monoclonal\N5P
2391	TOK	in		in\P
2392	TOK	their		their\APP3N6
2393	TOK	milk		milk\N5S
2394	TOK	can		can\VOFDR66
2395	TOK	generate		generate\VMI----
2396	TOK	one		one\MCS
2397	TOK	gram		gram\N5S
2398	TOK	of		of\P
2399	TOK	antibody		antibody\N5S
2400	TOK	for		for\P
2401	TOK	roughly		roughly\DGA7
2402	TOK	$		$\N5P
##	TAG	<num>
2403	TOK	100		100\X
##	TAG	</num>
---	DLE	-		=\DELIM
---	DLD	-		=\DELIM
2404	TOK	one		one\MCS
2405	TOK	third		third\MOS
2406	TOK	the		the\AT---6
2407	TOK	cost		cost\N5S
2408	TOK	of		of\P
2409	TOK	traditional		traditional\JA
2410	TOK	production		production\N5S
2411	TOK	methods		method\N5P
---	DLD	,		=\DELIM
2412	TOK	industry		industry\N5S
2413	TOK	officials		official\N5P
2414	TOK	say		say\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2415	TOK	Centocor	BOS	Centocor\N46
##	TAG	</name>
2416	TOK	and		and\CC
##	TAG	<name>
2417	TOK	Johnson & Johnson		Johnson_&_Johnson\N46
##	TAG	</name>
2418	TOK	are		be\V6FDR66
2419	TOK	looking		look\VMG----
2420	TOK	into		into\P
2421	TOK	producing		produce\VMG----
##	TAG	<name>
2422	TOK	Remicade		Remicade\N46
##	TAG	</name>
2423	TOK	using		use\VMG----
2424	TOK	transgenic		transgenic\JA
2425	TOK	goats		goat\N5P
---	DLD	,		=\DELIM
2426	TOK	and		and\CC
##	TAG	<name>
2427	TOK	Infigen		Infigen\N46
##	TAG	</name>
2428	TOK	in		in\P
##	TAG	<name>
2429	TOK	DeForest		DeForest\N46
##	TAG	</name>
---	DLE	,		=\DELIM
##	TAG	<abbr>
2430	TOK	Wis.		Wis.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
2431	TOK	intends		intend\VMFDRS3
2432	TOK	to		to\P
2433	TOK	make		make\VMI----
2434	TOK	monoclonals		monoclonal\N5P
2435	TOK	in		in\P
2436	TOK	cow		cow\N5S
2437	PGR	's		genmark\GENMARK
2438	TOK	milk		milk\N5S
---	DLD	,		=\DELIM
2439	TOK	although		although\CS
##	TAG	<loc pos="AG---6">
2440	TOK	no such		no_such\AG---6
##	TAG	</loc>
2441	TOK	products		product\N5P
2442	TOK	have		have\V6F6R66
2443	TOK	yet		yet\DGA7
2444	TOK	received		receive\VMC----
##	TAG	<name>
2445	TOK	FDA		FDA\N46
##	TAG	</name>
2446	TOK	approval		approval\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2447	TOK	Moreover	BOS	moreover\DGA7
---	DLD	,		=\DELIM
2448	TOK	it		it\RPS3N6
2449	TOK	isn		be\V6FDRS3
2450	PGR	't		not\DGA7
2451	TOK	clear		clear\VMI----
2452	TOK	how		how\DGAW
2453	TOK	many		many\AI---P
2454	TOK	companies		company\N5P
2455	TOK	will		will\VOFDR66
2456	TOK	be		be\VMI----
2457	TOK	willing		willing\JA
2458	TOK	to		to\P
2459	TOK	turn		turn\N5S
2460	TOK	to		to\P
2461	TOK	these		this\AD---P
2462	TOK	transgenic		transgenic\JA
2463	TOK	options		option\N5P
2464	TOK	over		over\P
2465	TOK	the		the\AT---6
2466	TOK	standard		standard\JA
2467	TOK	bioreactors		bioreactor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
2468	TOK	Newman	BOS	Newman\N46
##	TAG	</name>
2469	TOK	concedes		concede\VMFDRS3
2470	TOK	that		that\CS
2471	TOK	transgenic		transgenic\JA
2472	TOK	animals		animal\N5P
2473	TOK	are		be\V6FDR66
2474	TOK	attractive		attractive\JA
2475	TOK	alternatives		alternative\N5P
---	DLD	,		=\DELIM
2476	TOK	but		but\CC
2477	TOK	he		he\RPS3MN
2478	TOK	adds		add\VMFDRS3
2479	TOK	that		that\CS
2480	TOK	companies		company\N5P
2481	TOK	must		must\VOFDR66
2482	TOK	still		still\DGA7
2483	TOK	undergo		undergo\VMI----
2484	TOK	the		the\AT---6
2485	TOK	sometimes		sometimes\DGA7
2486	TOK	tedious		tedious\JA
2487	TOK	step		step\N5S
2488	TOK	of		of\P
2489	TOK	isolating		isolate\VMG----
2490	TOK	the		the\AT---6
2491	TOK	monoclonals		monoclonal\N5P
2492	TOK	from		from\P
2493	TOK	the		the\AT---6
2494	TOK	milk		milk\N5S
2495	TOK	proteins		protein\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
2496	TOK	You		you\RP62N6
2497	TOK	have		have\V6F6R66
2498	TOK	purification		purification\N5S
2499	TOK	problems		problem\N5P
---	DLD	,		=\DELIM
2500	TOK	but		but\CC
2501	TOK	you		you\RP62N6
2502	TOK	don		do\V6FDR66
2503	PGR	't		not\DGA7
2504	TOK	have		have\VMI----
2505	TOK	the		the\AT---6
2506	TOK	expense		expense\N5S
2507	TOK	of		of\P
##	TAG	<num>
2508	TOK	10,000		10,000\X
##	TAG	</num>
---	DLE	-		=\DELIM
2509	TOK	liter		liter\N5S
2510	TOK	bioreactors		bioreactor\N5P
---	DLD	,		=\DELIM
---	DLD	"		=\DELIM
2511	TOK	he		he\RPS3MN
2512	TOK	says		say\VMFDRS3
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2513	TOK	Genetically	BOS	genetically\DGA7
2514	TOK	engineering		engineering\N5S
2515	TOK	and		and\CC
2516	TOK	breeding		breed\VMG----
2517	TOK	the		the\AT---6
2518	TOK	animals		animal\N5P
2519	TOK	can		can\VOFDR66
2520	TOK	also		also\DGA7
2521	TOK	take		take\VMI----
2522	TOK	years		year\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
2523	TOK	Mich B. Hein	BOS	Mich_B._Hein\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2524	TOK	president		president\N5S
2525	TOK	of		of\P
##	TAG	<name>
2526	TOK	Epicyte		Epicyte\N46
##	TAG	</name>
2527	TOK	in		in\P
##	TAG	<name pos="N46" type="place">
2528	TOK	San Diego		San_Diego\N46
##	TAG	</name>
---	DLE	,		=\DELIM
2529	TOK	sees		see\VMFDRS3
2530	TOK	green		green\JA
2531	TOK	plants		plant\N5P
2532	TOK	as		as\P
2533	TOK	the		the\AT---6
2534	TOK	answer		answer\N5S
2535	TOK	to		to\P
2536	TOK	the		the\AT---6
2537	TOK	monoclonal		monoclonal\JA
2538	TOK	production		production\N5S
2539	TOK	shortfall		shortfall\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
---	DLE	"	BOS	=\DELIM
2540	TOK	It		it\RPS3N6
2541	PGR	's		be\V6FDRS3
2542	TOK	pretty		pretty\DGA7
2543	TOK	clear		clear\JA
2544	TOK	that		that\CS
2545	TOK	the		the\AT---6
2546	TOK	production		production\N5S
2547	TOK	facilities		facility\N5P
2548	TOK	will		will\VOFDR66
2549	TOK	not		not\DGA7
2550	TOK	meet		meet\VMI----
2551	TOK	the		the\AT---6
2552	TOK	demand		demand\N5S
2553	TOK	for		for\P
2554	TOK	even		even\DGA7
2555	TOK	the		the\AT---6
2556	TOK	most		most\DDS7
2557	TOK	promising		promising\JA
2558	TOK	molecules		molecule\N5P
---	DLD	,		=\DELIM
---	DLD	"		=\DELIM
2559	TOK	he		he\RPS3MN
2560	TOK	says		say\VMFDRS3
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2561	TOK	Plants	BOS	plant\N5P
2562	TOK	have		have\V6F6R66
2563	TOK	the		the\AT---6
2564	TOK	advantages		advantage\N5P
2565	TOK	of		of\P
2566	TOK	being		be\VMG----
2567	TOK	economical		economical\JA
2568	TOK	and		and\CC
2569	TOK	easily		easily\DGA7
2570	TOK	scalable		scalable\JA
2571	TOK	to		to\P
2572	TOK	any		any\AG---6
2573	TOK	level		level\N5S
2574	TOK	of		of\P
2575	TOK	demand		demand\VMI----
---	DLD	:		=\DELIM
2576	TOK	they		they\RPP3NN
2577	TOK	can		can\VOFDR66
2578	TOK	yield		yield\VMI----
2579	TOK	metric		metric\JA
2580	TOK	tons		ton\N5P
2581	TOK	of		of\P
2582	TOK	monoclonal		monoclonal\JA
2583	TOK	products		product\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2584	TOK	But	BOS	but\CC
2585	TOK	purification		purification\N5S
2586	TOK	problems		problem\N5P
2587	TOK	remain		remain\VMF6R66
---	DLD	,		=\DELIM
2588	TOK	and		and\CC
2589	TOK	it		it\RPS3N6
2590	TOK	is		be\V6FDRS3
2591	TOK	still		still\DGA7
2592	TOK	unclear		unclear\JA
2593	TOK	how		how\DGAW
2594	TOK	the		the\AT---6
##	TAG	<name>
2595	TOK	FDA		FDA\N46
##	TAG	</name>
2596	TOK	will		will\VOFDR66
2597	TOK	regulate		regulate\VMI----
2598	TOK	pharmaceuticals		pharmaceutical\N5P
2599	TOK	produced		produce\VMC----
2600	TOK	by		by\P
2601	TOK	transgenic		transgenic\JA
2602	TOK	plants		plant\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
2603	TOK	Epicyte	BOS	Epicyte\N46
##	TAG	</name>
2604	TOK	has		have\V6FDRS3
2605	TOK	teamed		team\VMC----
2606	TOK	up		up\P
2607	TOK	with		with\P
##	TAG	<name>
2608	TOK	Dow		Dow\N46
##	TAG	</name>
2609	TOK	to		to\P
2610	TOK	produce		produce\VMI----
2611	TOK	corn		corn\N5S
2612	TOK	plants		plant\N5P
2613	TOK	able		able\JA
2614	TOK	to		to\P
2615	TOK	generate		generate\VMI----
2616	TOK	monoclonal		monoclonal\JA
2617	TOK	antibodies		antibody\N5P
2618	TOK	that		that\RW63N6
2619	TOK	will		will\VOFDR66
2620	TOK	be		be\VMI----
2621	TOK	formulated		formulate\VMC----
2622	TOK	as		as\P
2623	TOK	creams		cream\N5P
2624	TOK	or		or\CC
2625	TOK	ointments		ointment\N5P
2626	TOK	for		for\P
2627	TOK	mucosal		mucosal\JA
2628	TOK	surfaces		surface\N5P
2629	TOK	such		such\RIS3N-
2630	TOK	as		as\P
2631	TOK	the		the\AT---6
2632	TOK	lips		lip\N5P
2633	TOK	and		and\CC
2634	TOK	genitalia		genitalia\N5P
2635	TOK	or		or\CC
2636	TOK	as		as\DGA7
2637	TOK	orally		orally\DGA7
2638	TOK	administered		administer\VMC----
2639	TOK	drugs		drug\N5P
2640	TOK	for		for\P
2641	TOK	gastrointestinal		gastrointestinal\JA
2642	TOK	or		or\CC
2643	TOK	respiratory		respiratory\JA
2644	TOK	infections		infection\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2645	TOK	Hein	BOS	Hein\N46
##	TAG	</name>
2646	TOK	predicts		predict\VMFDRS3
2647	TOK	that		that\CS
2648	TOK	by		by\P
2649	TOK	the		the\AT---6
2650	TOK	end		end\N5S
2651	TOK	of		of\P
2652	TOK	next		next\JA
2653	TOK	year		year\N5S
##	TAG	<name>
2654	TOK	Epicyte		Epicyte\N46
##	TAG	</name>
2655	TOK	will		will\VOFDR66
2656	TOK	seek		seek\VMI----
##	TAG	<name>
2657	TOK	FDA		FDA\N46
##	TAG	</name>
2658	TOK	clearance		clearance\N5S
2659	TOK	to		to\P
2660	TOK	begin		begin\VMI----
2661	TOK	clinical		clinical\JA
2662	TOK	trials		trial\N5P
2663	TOK	of		of\P
2664	TOK	corn		corn\VMI----
---	DLI	-		=\DELIM
2665	TOK	produced		produce\VMC----
2666	TOK	monoclonals		monoclonal\N5P
2667	TOK	to		to\P
2668	TOK	prevent		prevent\VMI----
2669	TOK	the		the\AT---6
2670	TOK	transmission		transmission\N5S
2671	TOK	of		of\P
2672	TOK	herpes		herpes\N5S
2673	TOK	simplex		simplex\JA
2674	TOK	between		between\P
2675	TOK	adults		adult\N5P
2676	TOK	and		and\CC
2677	TOK	during		during\P
2678	TOK	childbirth		childbirth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2679	TOK	The	BOS	the\AT---6
2680	TOK	company		company\N5S
2681	TOK	is		be\V6FDRS3
2682	TOK	also		also\DGA7
2683	TOK	developing		developing\JA
2684	TOK	monoclonals		monoclonal\N5P
2685	TOK	that		that\RW63N6
2686	TOK	bind		bind\VMF6R66
2687	TOK	to		to\P
2688	TOK	sperm		sperm\N56
2689	TOK	as		as\P
2690	TOK	possible		possible\JA
2691	TOK	contraceptives		contraceptive\N5P
---	DLD	,		=\DELIM
##	TAG	<loc pos="DGA7">
2692	TOK	as well as		as_well_as\DGA7
##	TAG	</loc>
2693	TOK	antibodies		antibody\N5P
2694	TOK	that		that\RW63N6
2695	TOK	could		can\VOFDA66
2696	TOK	protect		protect\VMI----
2697	TOK	against		against\P
2698	TOK	human		human\JA
2699	TOK	papillomavirus		papillomavirus\N5S
---	DLD	,		=\DELIM
2700	TOK	which		which\RW63N-
2701	TOK	causes		cause\VMFDRS3
2702	TOK	genital		genital\JA
2703	TOK	warts		wart\N5P
2704	TOK	and		and\CC
2705	TOK	cervical		cervical\JA
2706	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2707	TOK	Whether	BOS	whether\CS
2708	TOK	they		they\RPP3NN
2709	TOK	come		come\VMF6R66
2710	TOK	from		from\P
2711	TOK	cattle		cattle\N5P
---	DLD	,		=\DELIM
2712	TOK	goats		goat\N5P
---	DLD	,		=\DELIM
2713	TOK	corn		corn\N5S
2714	TOK	or		or\CC
2715	TOK	bioreactors		bioreactor\N5P
---	DLD	,		=\DELIM
2716	TOK	monoclonal		monoclonal\JA
2717	TOK	antibodies		antibody\N5P
2718	TOK	are		be\V6FDR66
2719	TOK	set		set\VMC----
2720	TOK	to		to\P
2721	TOK	become		become\VMI----
2722	TOK	a		a\AI---S
2723	TOK	major		major\JA
2724	TOK	part		part\N5S
2725	TOK	of		of\P
##	TAG	<num>
2726	TOK	21st		21st\X
##	TAG	</num>
---	DLE	-		=\DELIM
2727	TOK	century		century\N5S
2728	TOK	medicine		medicine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
2729	TOK	Overview/ Monoclonal Antibodies	BOS	Overview/_Monoclonal_Antibodies\N46
##	TAG	</name>
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2731	TOK	Antibodies	BOS	antibody\N5P
2732	TOK	are		be\V6FDR66
2733	TOK	large		large\JA
---	DLD	,		=\DELIM
##	TAG	<name>
2734	TOK	Y-shaped		Y-shaped\N46
##	TAG	</name>
2735	TOK	molecules		molecule\N5P
2736	TOK	that		that\RW63N6
2737	TOK	cells		cell\N5P
2738	TOK	of		of\P
2739	TOK	the		the\AT---6
2740	TOK	immune		immune\JA
2741	TOK	system		system\N5S
2742	TOK	called		call\VMF6A66
2743	TOK	B		b\N5S
2744	TOK	lymphocytes		lymphocyte\N5P
2745	TOK	produce		produce\VMF6R66
2746	TOK	to		to\P
2747	TOK	fight		fight\VMI----
2748	TOK	invaders		invader\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2749	TOK	Monoclonal	BOS	monoclonal\JA
2750	TOK	antibodies		antibody\N5P
2751	TOK	are		be\V6FDR66
2752	TOK	made		make\VMC----
2753	TOK	by		by\P
2754	TOK	identical		identical\JA
2755	TOK	copies		copy\N5P
---	DLD	,		=\DELIM
2756	TOK	or		or\CC
2757	TOK	clones		clone\VMFDRS3
---	DLD	,		=\DELIM
2758	TOK	of		of\P
2759	TOK	one		one\MCS
2760	TOK	single		single\JA
2761	TOK	B		b\N5S
2762	TOK	lymphocyte		lymphocyte\N5S
---	DLD	,		=\DELIM
2763	TOK	so		so\DGA7
2764	TOK	they		they\RPP3NN
2765	TOK	attack		attack\VMF6R66
2766	TOK	only		only\DGA7
2767	TOK	one		one\MCS
2768	TOK	specific		specific\JA
2769	TOK	target		target\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2770	TOK	There	BOS	there\DGA7
2771	TOK	are		be\V6FDR66
##	TAG	<num>
2772	TOK	10		10\X
##	TAG	</num>
2773	TOK	monoclonal		monoclonal\JA
2774	TOK	antibodies		antibody\N5P
2775	TOK	now		now\DGA7
2776	TOK	on		on\P
2777	TOK	the		the\AT---6
2778	TOK	market		market\N5S
---	DLD	,		=\DELIM
2779	TOK	to		to\P
2780	TOK	do		do\VMI----
2781	TOK	everything		everything\RIS3N-
2782	TOK	from		from\P
2783	TOK	preventing		prevent\VMG----
2784	TOK	organ		organ\N5S
---	DLI	-		=\DELIM
2785	TOK	transplant		transplant\N5S
2786	TOK	rejection		rejection\N5S
2787	TOK	to		to\P
2788	TOK	treating		treat\VMG----
2789	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
2790	TOK	Three	BOS	Three\X
##	TAG	</num>
2791	TOK	more		more\N5S
2792	TOK	are		be\V6FDR66
2793	TOK	waiting		wait\VMG----
2794	TOK	in		in\P
2795	TOK	the		the\AT---6
2796	TOK	wings		wing\N5P
2797	TOK	for		for\P
##	TAG	<name>
2798	TOK	Food		Food\N46
##	TAG	</name>
2799	TOK	and		and\CC
##	TAG	<name>
2800	TOK	Drug Administration		Drug_Administration\N46
##	TAG	</name>
2801	TOK	approval		approval\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2802	TOK	Although	BOS	although\CS
2803	TOK	monoclonal		monoclonal\JA
2804	TOK	antibodies		antibody\N5P
2805	TOK	are		be\V6FDR66
2806	TOK	usually		usually\DGA7
2807	TOK	produced		produce\VMC----
2808	TOK	by		by\P
2809	TOK	mammalian		mammalian\JA
2810	TOK	cells		cell\N5P
2811	TOK	called		call\VMC----
2812	TOK	hybridomas		hybridoma\N5P
---	DLD	,		=\DELIM
2813	TOK	scientists		scientist\N5P
2814	TOK	are		be\V6FDR66
2815	TOK	working		work\VMG----
2816	TOK	to		to\P
2817	TOK	derive		derive\VMI----
2818	TOK	them		them\RPP3NA
2819	TOK	from		from\P
2820	TOK	the		the\AT---6
2821	TOK	milk		milk\N5S
2822	TOK	of		of\P
2823	TOK	genetically		genetically\DGA7
2824	TOK	engineered		engineer\VMC----
2825	TOK	animals		animal\N5P
2826	TOK	and		and\CC
2827	TOK	from		from\P
2828	TOK	transgenic		transgenic\JA
2829	TOK	plants		plant\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2830	TOK	Monoclonal	BOS	monoclonal\JA
2831	TOK	antibodies		antibody\N5P
---	DLI	-		=\DELIM
---	DLI	-		=\DELIM
2832	TOK	also		also\DGA7
2833	TOK	called		call\VMF6A66
##	TAG	<name>
2834	TOK	MAbs--are		MAbs--are\N46
##	TAG	</name>
2835	TOK	cheaper		cheap\JC
2836	TOK	and		and\CC
2837	TOK	faster		fast\JC
2838	TOK	to		to\P
2839	TOK	ready		ready\JA
2840	TOK	for		for\P
2841	TOK	clinical		clinical\JA
2842	TOK	trials		trial\N5P
2843	TOK	than		than\CS
2844	TOK	traditional		traditional\JA
2845	TOK	drugs		drug\N5P
---	DLD	,		=\DELIM
2846	TOK	which		which\RW63N-
2847	TOK	are		be\V6FDR66
2848	TOK	made		make\VMC----
2849	TOK	of		of\P
2850	TOK	small		small\JA
---	DLD	,		=\DELIM
2851	TOK	inorganic		inorganic\JA
2852	TOK	molecules		molecule\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2853	TOK	Making	BOS	make\VMG----
##	TAG	<name>
2854	TOK	Monoclonals-Part One	EOS	Monoclonals-Part_One\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2856	TOK	The	BOS	the\AT---6
2857	TOK	traditional		traditional\JA
2858	TOK	technique		technique\N5S
2859	TOK	involves		involve\VMFDRS3
2860	TOK	fused		fuse\VMC----
2861	TOK	cells		cell\N5P
2862	TOK	called		call\VMC----
2863	TOK	hybridomas		hybridoma\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<num>
2864	TOK	1	BOS	1\X
##	TAG	</num>
2865	TOK	Inject		Inject\N5S
2866	TOK	mouse		mouse\N5S
2867	TOK	with		with\P
2868	TOK	antigen		antigen\N5S
2869	TOK	to		to\P
2870	TOK	elicit		elicit\VMI----
2871	TOK	production		production\N5S
2872	TOK	of		of\P
2873	TOK	antibodies		antibody\N5P
2874	TOK	against		against\P
2875	TOK	the		the\AT---6
2876	TOK	antigen		antigen\N5S
##	TAG	<na type="code">
2877	TOK	2a		noanat\W
##	TAG	</na>
##	TAG	<name>
2878	TOK	Isolate		Isolate\N46
##	TAG	</name>
2879	TOK	variety		variety\N5S
2880	TOK	of		of\P
2881	TOK	B		b\N5S
2882	TOK	lymphocytes		lymphocyte\N5P
---	DLE	(		=\DELIM
2883	TOK	antibody		antibody\N5S
---	DLI	-		=\DELIM
2884	TOK	producing		produce\VMG----
2885	TOK	cells		cell\N5P
---	DLD	)		=\DELIM
2886	TOK	from		from\P
2887	TOK	spleen		spleen\N5S
##	TAG	<na type="code">
2888	TOK	3b		noanat\W
##	TAG	</na>
##	TAG	<name>
2889	TOK	Collect		Collect\N46
##	TAG	</name>
2890	TOK	immortal		immortal\JA
2891	TOK	B		b\N5S
2892	TOK	lymphocytes		lymphocyte\N5P
2893	TOK	from		from\P
2894	TOK	a		a\AI---S
2895	TOK	human		human\JA
2896	TOK	bone		bone\N5S
2897	TOK	marrow		marrow\N5S
2898	TOK	cancer		cancer\N5S
---	DLE	(		=\DELIM
2899	TOK	myeloma		myeloma\N5S
---	DLD	)		=\DELIM
##	TAG	<num>
2900	TOK	4		4\X
##	TAG	</num>
##	TAG	<name>
2901	TOK	Fuse		Fuse\N46
##	TAG	</name>
2902	TOK	cells		cell\N5P
---	DLD	,		=\DELIM
2903	TOK	forming		form\VMG----
2904	TOK	hybridomas		hybridoma\N5P
---	DLD	,		=\DELIM
##	TAG	<name>
2905	TOK	Unfused		Unfused\N46
##	TAG	</name>
2906	TOK	cells		cell\N5P
2907	TOK	die		die\VMF6R66
##	TAG	<num>
2908	TOK	5		5\X
##	TAG	</num>
##	TAG	<name>
2909	TOK	Separate		Separate\N46
##	TAG	</name>
2910	TOK	hybridomas		hybridoma\N5P
2911	TOK	and		and\CC
2912	TOK	allow		allow\VMF6R66
2913	TOK	to		to\P
2914	TOK	divide		divide\VMI----
2915	TOK	into		into\P
2916	TOK	cultures		culture\N5P
##	TAG	<num>
2917	TOK	6		6\X
##	TAG	</num>
##	TAG	<name>
2918	TOK	Select		Select\N46
##	TAG	</name>
2919	TOK	hybridomas		hybridoma\N5P
2920	TOK	culture		culture\N5S
2921	TOK	that		that\RW63N6
2922	TOK	makes		make\VMFDRS3
2923	TOK	antibody		antibody\N5S
2924	TOK	that		that\RW63N6
2925	TOK	binds		bind\VMFDRS3
2926	TOK	to		to\P
2927	TOK	original		original\JA
2928	TOK	antigen		antigen\N5S
##	TAG	<num>
2929	TOK	7		7\X
##	TAG	</num>
##	TAG	<name>
2930	TOK	Propagate		Propagate\N46
##	TAG	</name>
2931	TOK	hybridomas		hybridoma\N5P
2932	TOK	in		in\P
2933	TOK	laboratory		laboratory\N5S
2934	TOK	cultures		culture\N5P
2935	TOK	or		or\CC
2936	TOK	in		in\P
2937	TOK	mice		mouse\N5P
##	TAG	<num>
2938	TOK	8		8\X
##	TAG	</num>
##	TAG	<name>
2939	TOK	Purify		Purify\N46
##	TAG	</name>
2940	TOK	antibodies		antibody\N5P
2941	TOK	from		from\P
2942	TOK	cultures		culture\N5P
2943	TOK	or		or\CC
2944	TOK	mice	EOS	mouse\N5P
##	TAG	</head>
##	TAG	<head>
2945	TOK	Making	BOS	making\N5S
##	TAG	<name>
2946	TOK	Monoclonals--Part		Monoclonals--Part\N46
##	TAG	</name>
##	TAG	<num>
2947	TOK	Two	EOS	Two\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2949	TOK	Viruses	BOS	virus\N5P
2950	TOK	called		call\VMC----
2951	TOK	phages		phage\N5P
2952	TOK	that		that\RW63N6
2953	TOK	infect		infect\VMF6R66
2954	TOK	bacteria		bacteria\N5P
2955	TOK	can		can\VOFDR66
2956	TOK	be		be\VMI----
2957	TOK	used		use\VMC----
##	TAG	<loc pos="CS">
2958	TOK	instead of		instead_of\CS
##	TAG	</loc>
2959	TOK	hybridomas		hybridoma\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<num>
2960	TOK	1	BOS	1\X
##	TAG	</num>
2961	TOK	Insert		insert\N5S
2962	TOK	genes		gene\N5P
2963	TOK	encoding		encode\VMG----
2964	TOK	a		a\AI---S
2965	TOK	variety		variety\N5S
2966	TOK	of		of\P
2967	TOK	the		the\AT---6
2968	TOK	antigen		antigen\N5S
---	DLI	-		=\DELIM
2969	TOK	binding		binding\N5S
2970	TOK	fragments		fragment\N5P
2971	TOK	of		of\P
2972	TOK	antibodies		antibody\N5P
2973	TOK	into		into\P
2974	TOK	bacteria		bacteria\N5P
2975	TOK	and		and\CC
2976	TOK	infect		infect\VMF6R66
2977	TOK	the		the\AT---6
2978	TOK	bacteria		bacteria\N5P
2979	TOK	with		with\P
2980	TOK	phages		phage\N5P
##	TAG	<num>
2981	TOK	2		2\X
##	TAG	</num>
##	TAG	<name>
2982	TOK	Infected		Infected\N46
##	TAG	</name>
2983	TOK	bacteria		bacteria\N5P
2984	TOK	make		make\VMF6R66
2985	TOK	new		new\JA
2986	TOK	phages		phage\N5P
---	DLD	,		=\DELIM
2987	TOK	each		each\RIS3N-
2988	TOK	of		of\P
2989	TOK	which		which\RW63N-
2990	TOK	incorporates		incorporate\VMFDRS3
2991	TOK	a		a\AI---S
2992	TOK	different		different\JA
2993	TOK	antibody		antibody\N5S
2994	TOK	fragment		fragment\N5S
2995	TOK	at		at\P
2996	TOK	its		its\APS3N6
2997	TOK	tip		tip\N5S
##	TAG	<num>
2998	TOK	3		3\X
##	TAG	</num>
##	TAG	<name>
2999	TOK	Screen		Screen\N46
##	TAG	</name>
3000	TOK	the		the\AT---6
3001	TOK	mixture		mixture\N5S
3002	TOK	of		of\P
3003	TOK	phages		phage\N5P
3004	TOK	to		to\P
3005	TOK	select		select\VMI----
3006	TOK	only		only\DGA7
3007	TOK	those		that\RDP3N-
3008	TOK	with		with\P
3009	TOK	antibody		antibody\N5S
3010	TOK	fragments		fragment\N5P
3011	TOK	that		that\RW63N6
3012	TOK	bind		bind\VMF6R66
3013	TOK	specifically		specifically\DGA7
3014	TOK	to		to\P
3015	TOK	the		the\AT---6
3016	TOK	desired		desire\VMC----
3017	TOK	target		target\N5S
3018	TOK	antigen		antigen\N5S
##	TAG	<num>
3019	TOK	4		4\X
##	TAG	</num>
##	TAG	<name>
3020	TOK	Add		Add\N46
##	TAG	</name>
3021	TOK	the		the\AT---6
3022	TOK	genes		gene\N5P
3023	TOK	from		from\P
3024	TOK	the		the\AT---6
3025	TOK	selected		select\VMC----
3026	TOK	phages		phage\N5P
3027	TOK	back		back\DGA7
3028	TOK	to		to\P
3029	TOK	bacteria		bacteria\N5P
3030	TOK	to		to\P
3031	TOK	make		make\VMI----
3032	TOK	more		more\DDC7
3033	TOK	of		of\P
3034	TOK	the		the\AT---6
3035	TOK	specific		specific\JA
3036	TOK	antibody		antibody\N5S
3037	TOK	fragments		fragment\N5P
##	TAG	<num>
3038	TOK	5		5\X
##	TAG	</num>
3039	TOK	Put		put\N5S
3040	TOK	the		the\AT---6
3041	TOK	antibody		antibody\N5S
3042	TOK	fragments		fragment\N5P
3043	TOK	onto		onto\P
3044	TOK	antibody		antibody\N5S
3045	TOK	backbones		backbone\N5P
3046	TOK	to		to\P
3047	TOK	make		make\VMI----
3048	TOK	whole		whole\JA
3049	TOK	antibodies	EOS	antibody\N5P
##	TAG	</head>
##	TAG	</div1>
